The present disclosure relates generally to patient monitoring devices and specifically to a patient monitor and medical data communication hub.
Today's patient monitoring environments are crowded with sophisticated and often electronic medical devices servicing a wide variety of monitoring and treatment endeavors for a given patient. Generally, many if not all of the devices are from differing manufactures, and many may be portable devices. The devices may not communicate with one another and each may include its own control, display, alarms, configurations and the like. Complicating matters, caregivers often desire to associate all types of measurement and use data from these devices to a specific patient. Thus, patient information entry often occurs at each device. Sometimes, the disparity in devices leads to a need to simply print and store paper from each device in a patient's file for caregiver review.
The result of such device disparity is often a caregiver environment scattered with multiple displays and alarms leading to a potentially chaotic experience. Such chaos can be detrimental to the patient in many situations including surgical environments where caregiver distraction is unwanted, and including recovery or monitoring environments where patient distraction or disturbance may be unwanted.
Various manufacturers produce multi-monitor devices or devices that modularly expand to increase the variety of monitoring or treatment endeavors a particular system can accomplish. However, as medical device technology expands, such multi-monitor devices begin to be obsolete the moment they are installed.
This disclosure describes embodiments of a medical monitoring hub as the center of monitoring for a monitored patient. The hub can include configurable medical ports and serial ports for communicating with other medical devices in the patient's proximity. Moreover, the hub can communicate with a portable patient monitor. The monitor, when docked with the hub, may provide display graphics different from when undocked. The display graphics can include anatomical information. The hub can assemble the often vast amount of electronic medical data, associate it with the monitored patient, and in some embodiments, communicate the data to the patient's medical records.
Some aspects of the disclosure describe a first medical device having digital logic circuitry receives a physiological signal associated with a patient from a physiological sensor, obtains a first physiological parameter value based on the physiological signal, and outputs the first physiological parameter value for display. The first medical device can also receive a second physiological parameter value from a second medical device other than the first medical device, where the second physiological parameter value is formatted according to a protocol not used by the first medical device, such that the first medical device is not able to process the second physiological parameter value to produce a displayable output value. The first medical device can pass the physiological parameter data from the first medical device to a separate translation module, receive translated parameter data from the translation module at the first medical device, where the translated parameter data is able to be processed for display by the first medical device, and output a second value from the translated parameter data for display. The first medical device may be, for example, a monitoring hub, a portable physiological monitor, or a multi-patient monitoring system, and the second medical device may be an infusion pump, ventilator, or the like.
For purposes of summarizing the disclosure, certain aspects, advantages and novel features are discussed herein. It is to be understood that not necessarily all such aspects, advantages or features will be embodied in any particular embodiment of the invention and an artisan would recognize from the disclosure herein a myriad of combinations of such aspects, advantages or features.
The following drawings and the associated descriptions are provided to illustrate embodiments of the present disclosure and do not limit the scope of the claims.
While the foregoing “Brief Description of the Drawings” references generally various embodiments of the disclosure, an artisan will recognize from the disclosure herein that such embodiments are not mutually exclusive. Rather, the artisan would recognize a myriad of combinations of some or all of such embodiments.
I. Introduction
Based on at least the foregoing, a solution is needed that coordinates the various medical devices treating or monitoring a patient. Embodiments of such a solution should provide patient identification seamlessly across the device space and embodiments of such a solution should expand for future technologies without necessarily requiring repeated software upgrades. In addition, embodiments of such a solution may include patient electrical isolation where desired.
Therefore, the present disclosure relates to a patient monitoring hub that is the center of patient monitoring and treatment activities for a given patient. Embodiments of the patient monitoring hub interface with legacy devices without necessitating legacy reprogramming, provide flexibility for interfacing with future devices without necessitating software upgrades, and offer optional patient electrical isolation. In an embodiment, the hub includes a large display dynamically providing information to a caregiver about a wide variety of measurement or otherwise determined parameters. Additionally, in an embodiment, the hub includes a docking station for a portable patient monitor. The portable patient monitor may communicate with the hub through the docking station or through various wireless paradigms known to an artisan from the disclosure herein, including WiFi, Bluetooth, Zigbee, or the like.
In still other embodiments, the portable patient monitor modifies its screen when docked. The undocked display indicia is in part or in whole transferred to a large dynamic display of the hub and the docked display presents one or more anatomical graphics of monitored body parts. For example, the display may present a heart, lungs, a brain, kidneys, intestines, a stomach, other organs, digits, gastrointestinal systems or other body parts when it is docked. In an embodiment, the anatomical graphics may advantageously be animated. In an embodiment, the animation may generally follow the behavior of measured parameters, such as, for example, the lungs may inflate in approximate correlation to the measured respiration rate and/or the determined inspiration portion of a respiration cycle, and likewise deflate according to the expiration portion of the same. The heart may beat according to the pulse rate, may beat generally along understood actual heart contraction patterns, and the like. Moreover, in an embodiment, when the measured parameters indicate a need to alert a caregiver, a changing severity in color may be associated with one or more displayed graphics, such as the heart, lungs, brain, or the like. In still other embodiments, the body portions may include animations on where, when or how to attach measurement devices to measurement sites on the patient. For example, the monitor may provide animated directions for CCHD screening procedures or glucose strip reading protocols, the application of a forehead sensor, a finger or toe sensor, one or more electrodes, an acoustic sensor, and ear sensor, a cannula sensor or the like.
The present disclosure relates to a medical monitoring hub configured to be the center of monitoring activity for a given patient. In an embodiment, the hub comprises a large easily readable display, such as an about ten (10) inch display dominating the majority of real estate on a front face of the hub. The display could be much larger or much smaller depending upon design constraints. However, for portability and current design goals, the preferred display is roughly sized proportional to the vertical footprint of one of the dockable portable patient monitors. Other considerations are recognizable from the disclosure herein by those in the art.
The display provides measurement data for a wide variety of monitored parameters for the patient under observation in numerical or graphic form, and in various embodiments, is automatically configured based on the type of data and information being received at the hub. In an embodiment, the hub is moveable, portable, and mountable so that it can be positioned to convenient areas within a caregiver environment. For example, the hub is collected within a singular housing.
In an embodiment, the hub may advantageously receive data from a portable patient monitor while docked or undocked from the hub. Typical portable patient monitors, such as oximeters or co-oximeters can provide measurement data for a large number of physiological parameters derived from signals output from optical and/or acoustic sensors, electrodes, or the like. The physiological parameters include, but not limited to oxygen saturation, carboxy hemoglobin, methemoglobin, total hemoglobin, glucose, pH, bilirubin, fractional saturation, pulse rate, respiration rate, components of a respiration cycle, indications of perfusion including perfusion index, signal quality and/or confidences, plethysmograph data, indications of wellness or wellness indexes or other combinations of measurement data, audio information responsive to respiration, ailment identification or diagnosis, blood pressure, patient and/or measurement site temperature, depth of sedation, organ or brain oxygenation, hydration, measurements responsive to metabolism, combinations of the same or the like, to name a few. In other embodiments, the hub may output data sufficient to accomplish closed-loop drug administration in combination with infusion pumps or the like.
In an embodiment, the hub communicates with other devices in a monitoring environment that are interacting with the patient in a number of ways. For example, the hub advantageously receives serial data from other devices without necessitating their reprogramming or that of the hub. Such other devices include pumps, ventilators, all manner of monitors monitoring any combination of the foregoing parameters, ECG/EEG/EKG devices, electronic patient beds, and the like. Moreover, the hub advantageously receives channel data from other medical devices without necessitating their reprogramming or that of the hub. When a device communicates through channel data, the hub may advantageously alter the large display to include measurement information from that device. Additionally, the hub accesses nurse call systems to ensure that nurse call situations from the device are passed to the appropriate nurse call system.
The hub also communicates with hospital systems to advantageously associate incoming patient measurement and treatment data with the patient being monitored. For example, the hub may communicate wirelessly or otherwise to a multi-patient monitoring system, such as a server or collection of servers, which in turn many communicate with a caregiver's data management systems, such as, for example, an Admit, Discharge, Transfer (“ADT”) system and/or an Electronic Medical Records (“EMR”) system. The hub advantageously associates the data flowing through it with the patient being monitored thereby providing the electronic measurement and treatment information to be passed to the caregiver's data management systems without the caregiver associating each device in the environment with the patient.
In an embodiment, the hub advantageously includes a reconfigurable and removable docking station. The docking station may dock additional layered docking stations to adapt to different patient monitoring devices. Additionally, the docking station itself is modularized so that it may be removed if the primary dockable portable patient monitor changes its form factor. Thus, the hub is flexible in how its docking station is configured.
In an embodiment, the hub includes a large memory for storing some or all of the data it receives, processes, and/or associates with the patient, and/or communications it has with other devices and systems. Some or all of the memory may advantageously comprise removable SD memory.
The hub communicates with other devices through at least (1) the docking station to acquire data from a portable monitor, (2) innovative universal medical connectors to acquire channel data, (3) serial data connectors, such as RJ ports to acquire output data, (4) Ethernet, USB, and nurse call ports, (5) Wireless devices to acquire data from a portable monitor, (6) other wired or wireless communication mechanisms known to an artisan. The universal medical connectors advantageously provide optional electrically isolated power and communications, are designed to be smaller in cross section than isolation requirements. The connectors and the hub communicate to advantageously translate or configure data from other devices to be usable and displayable for the hub. In an embodiment, a software developers kit (“SDK”) is provided to a device manufacturer to establish or define the behavior and meaning of the data output from their device. When the output is defined, the definition is programmed into a memory residing in the cable side of the universal medical connector and supplied as an original equipment manufacture (“OEM”) to the device provider. When the cable is connected between the device and the hub, the hub understands the data and can use it for display and processing purposes without necessitating software upgrades to the device or the hub. In an embodiment, the hub can negotiate the schema and even add additional compression and/or encryption. Through the use of the universal medical connectors, the hub organizes the measurement and treatment data into a single display and alarm system effectively and efficiently bringing order to the monitoring environment.
As the hub receives and tracks data from other devices according to a channel paradigm, the hub may advantageously provide processing to create virtual channels of patient measurement or treatment data. In an embodiment, a virtual channel may comprise a non-measured parameter that is, for example, the result of processing data from various measured or other parameters. An example of such a parameter includes a wellness indicator derived from various measured parameters that give an overall indication of the wellbeing of the monitored patient. An example of a wellness parameter is disclosed in U.S. patent application Ser. Nos. 13/269,296, 13/371,767 and 12/904,925, by the assignee of the present disclosure and incorporated by reference herein. By organizing data into channels and virtual channels, the hub may advantageously time-wise synchronize incoming data and virtual channel data.
The hub also receives serial data through serial communication ports, such as RJ connectors. The serial data is associated with the monitored patient and passed on to the multi-patient server systems and/or caregiver backend systems discussed above. Through receiving the serial data, the caregiver advantageously associates devices in the caregiver environment, often from varied manufactures, with a particular patient, avoiding a need to have each individual device associated with the patient and possible communicating with hospital systems. Such association is vital as it reduces caregiver time spent entering biographic and demographic information into each device about the patient. Moreover, in an embodiment, through the SDK the device manufacturer may advantageously provide information associated with any measurement delay of their device, thereby further allowing the hub to advantageously time-wise synchronize serial incoming data and other data associated with the patient.
In an embodiment, when a portable patient monitor is docked, and it includes its own display, the hub effectively increases its display real estate. For example, in an embodiment, the portable patient monitor may simply continue to display its measurement and/or treatment data, which may be now duplicated on the hub display, or the docked display may alter its display to provide additional information. In an embodiment, the docked display, when docked, presents anatomical graphical data of, for example, the heart, lungs, organs, the brain, or other body parts being measured and/or treated. The graphical data may advantageously animate similar to and in concert with the measurement data. For example, lungs may inflate in approximate correlation to the measured respiration rate and/or the determined inspiration/expiration portions of a respiration cycle, the heart may beat according to the pulse rate, may beat generally along understood actual heart contraction patterns, the brain may change color or activity based on varying depths of sedation, or the like. In an embodiment, when the measured parameters indicate a need to alert a caregiver, a changing severity in color may be associated with one or more displayed graphics, such as the heart, lungs, brain, organs, circulatory system or portions thereof, respiratory system or portions thereof, other body parts or the like. In still other embodiments, the body portions may include animations on where, when or how to attach measurement devices.
The hub may also advantageously overlap parameter displays to provide additional visual information to the caregiver. Such overlapping may be user definable and configurable. The display may also incorporate analog-appearing icons or graphical indicia.
In the interest of clarity, not all features of an actual implementation are described in this specification. An artisan will of course be appreciate that in the development of any such actual implementation (as in any development project), numerous implementation-specific decisions must be made to achieve a developers' specific goals and subgoals, such as compliance with system- and business-related constraints, which will vary from one implementation to another. Moreover, it will be appreciated that such a development effort might be complex and time-consuming, but would nevertheless be a routine undertaking of device engineering for those of ordinary skill having the benefit of this disclosure.
To facilitate a complete understanding of the disclosure, the remainder of the detailed description describes the disclosure with reference to the drawings, wherein like reference numbers are referenced with like numerals throughout.
II. Example Hub Embodiments
In an embodiment, the display 104 may present a wide variety of measurement and/or treatment data in numerical, graphical, waveform, or other display indicia 110. In an embodiment, the display 104 occupies much of a front face of the housing 108, although an artisan will appreciate the display 104 may comprise a tablet or tabletop horizontal configuration, a laptop-like configuration or the like. Other embodiments may include communicating display information and data to a table computer, smartphone, television, or any display system recognizable to an artisan. The upright inclined configuration of
In an embodiment, the housing 108 may also include pockets or indentations to hold additional medical devices, such as, for example, a blood pressure monitor or temperature sensor 112, such as that shown in
The portable patient monitor 102 of
In an embodiment, the docking station 106 of the hub 100 includes a mechanical latch 118, or mechanically releasable catch to ensure that movement of the hub 100 doesn't mechanically detach the monitor 102 in a manner that could damage the same.
Although disclosed with reference to particular portable patient monitors 102, an artisan will recognize from the disclosure herein a large number and wide variety of medical devices that may advantageously dock with the hub 100. Moreover, the docking station 106 may advantageously electrically and not mechanically connect with the monitor 102, and/or wirelessly communicate with the same.
As disclosed, the portable patient monitor 102 communicates with the hub 100, in an embodiment, through the docking station 106 when docked and, in an embodiment, wirelessly when undocked, however, such undocked communication is not required. The hub 100 communicates with one or more multi-patient monitoring servers 204 or server systems, such as, for example, those disclosed with in U.S. Pat. Pub. Nos. 2011/0105854, 2011/0169644, and 2007/0180140. In general, the server 204 communicates with caregiver backend systems 206 such as EMR and/or ADT systems. The server 204 may advantageously obtain through push, pull or combination technologies patient information entered at patient admission, such as demographical information, billing information, and the like. The hub 100 accesses this information to seamlessly associate the monitored patient with the caregiver backend systems 206. Communication between the server 204 and the monitoring hub 100 may be any recognizable to an artisan from the disclosure herein, including wireless, wired, over mobile or other computing networks, or the like.
Although disclosed with reference to a single docking station 106, the environment 200 may include stacked docking stations where a subsequent docking station mechanically and electrically docks to a first docking station to change the form factor for a different portable patent monitor as discussed with reference to
An artisan will recognize from the disclosure herein that the instrument board 302 may comprise a large number of electronic components organized in a large number of ways. Using different boards such as those disclosed above advantageously provides organization and compartmentalization to the complex system.
The housing 108 of the hub 100 also includes cavity 406 housing the docking station 400. To the extent a change to the form factor for the portable patient monitor 102 occurs, the docking station 400 is advantageously removable and replaceable. Similar to the docking station 400, the hub 100 includes within the cavity 406 of the housing 108 electrical connectors 408 providing electrical communication to the docking station 400. In an embodiment, the docking station 400 includes its own microcontroller and processing capabilities, such as those disclosed in U.S. Pat. Pub. No. 2002/0140675. In other embodiments, the docking station 400 passes communications through to the electrical connector 408.
Moreover, using the memory 702, the host 602 may determine to simply not enable any unused power supplies, whether that be the isolated power or one or more of the higher voltage non-isolated power supplies, thereby increasing the efficiency of the host.
An artisan will recognize from the disclosure herein that hub 100 may not check to see if sufficient power is available or may provide one, two or many levels of non-isolated voltages based on information from the memory 702.
As shown from a different perspective in
Such open architecture advantageously provides device manufacturers the ability to port the output of their device into the hub 100 for display, processing, and data management as disclosed in the foregoing. By implementation through the cable connector, the device manufacturer avoids any reprogramming of their original device; rather, they simply let the hub 100 know through the cable connector how the already existing output is formatted. Moreover, by describing the data in a language already understood by the hub 100, the hub 100 also avoids software upgrades to accommodate data from “new-to-the-hub” medical devices.
Once the device provider describes the data, the hub provider creates a binary image or other file to store in a memory within a cable connector in step 1405; however, the SDK may create the image and simply communicated it to the hub provider. The cable connector is provided as an OEM part to the provider in step 1410, who constructs and manufactures the cable to mechanically and electrically mate with output ports on their devices in step 1412.
Once a caregiver has the appropriately manufactured cable, with one end matching the device provider's system and the other OEM'ed to match the hub 100 at its channel ports 212, in step 1452 the caregiver can connect the hub between the devices. In step 1454, the hub 100 reads the memory, provides isolated or non-isolated power, and the cable controller and the hub 100 negotiate a protocol or schema for data delivery. In an embodiment, a controller on the cable may negotiated the protocol, in an alternative embodiment, the controller of the hub 100 negotiates with other processors on the hub the particular protocol. Once the protocol is set, the hub 100 can use, display and otherwise process the incoming data stream in an intelligent manner.
Through the use of the universal medical connectors described herein, connection of a myriad of devices to the hub 100 is accomplished through straightforward programming of a cable connector as opposed to necessitating software upgrades to each device.
In
In
For example, acoustic data from an acoustic sensor may advantageously provide breath sound data, while the plethysmograph and ECG or other signals can also be presented in separate waveforms (
Providing a visual correlation between multiple physiological signals can provide a number of valuable benefits where the signals have some observable physiological correlation. As one example of such a correlation, changes in morphology (e.g., envelope and/or baseline) of the plethysmographic signal can be indicative of patient blood or other fluid levels. And, these changes can be monitored to detect hypovolemia or other fluid-level related conditions. A pleth variability index may provide an indication of fluid levels, for example. And, changes in the morphology of the plethysmographic signal are correlated to respiration. For example, changes in the envelope and/or baseline of the plethysmographic signal are correlated to breathing. This is at least in part due to aspects of the human anatomical structure, such as the mechanical relationship and interaction between the heart and the lungs during respiration.
Thus, superimposing a plethysmographic signal and a respiratory signal (
The monitor may also be configured to process the signals and determine whether there is a threshold level of correlation between the two signals, or otherwise assess the correlation. However, by additionally providing a visual indication of the correlation, such as by showing the signals superimposed with one another, the display provides operators a continuous, intuitive and readily observable gauge of the particular physiological correlation. For example, by viewing the superimposed signals, users can observe trends in the correlation over time, which may not be otherwise ascertainable.
The monitor can visually correlate a variety of other types of signals instead of, or in addition to plethysmographic and respiratory signals. For example,
In one embodiment, the hub 100 provides an interface through which the user can move the signals together to overlay on one another. For example, the user may be able to drag the respiration signal down onto the plethysmographic signal using a touch screen interface. Conversely, the user may be able to separate the signals, also using the touch screen interface. In another embodiment, the monitor includes a button the user can press, or some other user interface allowing the user to overlay and separate the signals, as desired.
In certain configurations, in addition to providing the visual correlation between the plethysmographic signal and the respiratory signal, the monitor is additionally configured to process the respiratory signal and the plethysmographic signal to determine a correlation between the two signals. For example, the monitor may process the signals to determine whether the peaks and valleys in the changes in the envelope and/or baseline of the plethysmographic signal correspond to bursts in the respiratory signal. And, in response to the determining that there is or is not a threshold level of correlation, the monitor may provide some indication to the user. For example, the monitor may provide a graphical indication (e.g., a change in color of pleth variability index indicator), an audible alarm, or some other indication. The monitor may employ one or more envelope detectors or other appropriate signal processing componentry in making the determination.
In certain embodiments, the system may further provide an audible indication of the patient's breathing sounds instead of, or in addition to the graphical indication. For example, the monitor may include a speaker, or an earpiece (e.g., a wireless earpiece) may be provided to the monitoring personnel providing an audible output of the patient sounds. Examples of sensors and monitors having such capability are described in U.S. Pat. Pub. No. 2011/0172561 and are incorporated by reference herein.
In addition to the above described benefits, providing both the acoustic and plethysmographic signals on the same display in the manner described can allow monitoring personnel to more readily detect respiratory pause events where there is an absence of breathing, high ambient noise that can degrade the acoustic signal, improper sensor placement, etc.
Each analog indicator of the health indicator can include a dial that moves about an arc based on measured levels of monitored physiological parameters. As the measured physiological parameter levels increase the dial can move clockwise, and as the measured physiological parameter levels decrease, the dial can move counter-clockwise, or vice versa. In this way, a user can quickly determine the patient's status by looking at the analog indicator. For example, if the dial is in the center of the arc, the observer can be assured that the current physiological parameter measurements are normal, and if the dial is skewed too far to the left or right, the observer can quickly assess the severity of the physiological parameter levels and take appropriate action. In other embodiments, normal parameter measurements can be indicated when the dial is to the right or left, etc.
In some embodiments, the dial can be implemented as a dot, dash, arrow, or the like, and the arc can be implemented as a circle, spiral, pyramid, or other shape, as desired. Furthermore, the entire arc can be lit up or only portions of the arc can be lit up based on the current physiological parameter measurement level. Furthermore, the arc can turn colors or be highlighted based on the current physiological parameter level. For example, as the dial approaches a threshold level, the arc and/or dial can turn from green, to yellow, to red, shine brighter, flash, be enlarged, move to the center of the display, or the like.
Different physiological parameters can have different thresholds indicating abnormal conditions. For example, some physiological parameters may upper a lower threshold levels, while others only have an upper threshold or a lower threshold. Accordingly, each health indicator can be adjusted based on the physiological parameter being monitored. For example, the SpO2 health indicator can have a lower threshold that when met activates an alarm, while the respiration rate health indicator can have both a lower and upper threshold, and when either is met an alarm is activated. The thresholds for each physiological parameter can be based on typical, expected thresholds and/or user-specified thresholds.
The digital indicator can provide a numerical representation of the current levels of the physiological parameter the digital indicator may indicate an actual level or a normalized level and can also be used to quickly assess the severity of a patient condition. In some embodiments, the display includes multiple health indicators for each monitored physiological parameter. In certain embodiments, the display includes fewer health indicators than the number of monitored physiological parameters. In such embodiments, the health indicators can cycle between different monitored physiological parameters.
The term “and/or” herein has its broadest least limiting meaning which is the disclosure includes A alone, B alone, both A and B together, or A or B alternatively, but does not require both A and B or require one of A or one of B. As used herein, the phrase “at least one of” A, B, “and” C should be construed to mean a logical A or B or C, using a non-exclusive logical or.
The term “plethysmograph” includes it ordinary broad meaning known in the art which includes data responsive to changes in volume within an organ or whole body (usually resulting from fluctuations in the amount of blood or air it contains).
III. Additional Monitoring Environment Embodiments
As described above, the hub 100 may receive serial data from a variety of medical equipment, including the patient's bed 214, infusion pumps 216, a ventilator 218, and other vital signs monitors 220. The hub 100 can pass serial data from these sources on to the MMS 2004. As described above, the MMS 2004 may then store the serial data in a caregiver backend system 206 such as an EMR system or ADT system.
The medical equipment providing this serial data may use a variety of different proprietary protocols, messaging infrastructure, and the like that may not be natively recognizable by the hub 100. Accordingly, the hub 100 may not have native capability to read parameter values or other data from this medical equipment, and as a result, may not have the capability to display parameter values or other data from these devices. Advantageously, however, the translation module 2005 at the MMS 2004 can receive serial data from these devices, translate the serial data into a format recognizable by the monitoring hub 100, and provide the serial data to the monitoring hub 100. The monitoring hub 100 can then read parameter values and other data from the translated information and output these values or data to a display, such as any of the displays described above.
In an embodiment, the translation module 2005 applies one or more translation rules to the serial data to translate or transform the serial data from one format to another format. The serial data may be formatted according to a Health Level Seven (“HL7”) protocol in one embodiment. The HL7 protocol has been developed to provide a messaging framework for the communication of clinical messages between medical computer systems and devices. However, the HL7 standard is quite flexible and merely provides a framework of guidelines. Consequently, medical devices or clinical computer systems that are all HL7-compliant may still be unable to communicate with each other. For example, the medical equipment 214-220 may each implement a version of the HL7 protocol, but these implementations may be different from an HL7 protocol implemented by the monitoring hub 100. Accordingly, the monitoring hub 100 may not be able to parse or read messages from the medical equipment 214-220, even though both use the HL7 standard. Further, the translation module 2005 may translate between different implementations of a common standard other than the HL7 protocol implemented by the hub 100 and medical equipment 214-220 in some embodiments.
In addition to translating between different implementations of a common electronic medical communication protocol (e.g., different formatting of HL7 messages), the translation module 2005 can also translate between input and output messages adhering to different communication protocols. In some embodiments, the translation module 2005 is capable of responding to and translating messages from, for example, one medical communication protocol to a separate medical communication protocol. For example, the translation module 2005 can facilitate communication between messages sent according to the HL7 protocol, the ISO 11073 protocol, other open protocols, or proprietary protocols. Accordingly, the translation module 2005 can translate an input message sent according to the HL7 protocol to an output message according to a different protocol, or vice-versa. In certain embodiments, the translation module 2005 can implement any of the translation features described below in greater detail under the section entitled “Translation Module Embodiments,” as well as further in U.S. application Ser. No. 14/032,132, filed Sep. 19, 2013, titled “Medical Monitoring System,” the disclosure of which is hereby incorporated by reference in its entirety.
Advantageously, in certain embodiments, the translation module 2005 can pass translated serial data back to the hub 100 or PPM 102. Since the translated data is in a format readable by the hub 100 or PPM 102, the hub 100 or PPM 102 can output the data from the medical equipment 214-220 on the display of the hub 100 or PPM 102. In addition, the translation module 2005 can provide the translated data to devices other than the hub 100, including clinician devices (such as cell phones, tablets, or pagers) and an auxiliary device 2040 that will be described below. Moreover, since the serial data provided by the medical equipment 214-220 may include alarm notifications, the translation module 2005 can pass these alarm notifications to the hub 100 or PPM 102. The hub 100 or PPM 102 can therefore generate visual or audible alarms responsive to these alarm notifications. Further, the translation module 2005 can provide the alarm notifications to clinician devices, e.g., over a hospital network or wide area network (such as the Internet). In addition, the translation module 2005 can provide the alarm notifications to the auxiliary device 2040.
The translation module 2005 is shown as implemented in the MMS 2004 because it may be beneficial to maintain and update the translation rules of the translation module 2005 in a single location. However, in other embodiments, the translation module 2005 may also be (or instead be) implemented in the hub 100 or PPM 102. Accordingly, the hub 100 or PPM 102 can access an internal translation module 2005 to translate serial data for output to the display of the hub 100 or PPM 102.
The auxiliary device 2040 can be a computing device having physical computer hardware, a display, and the like. For example, the auxiliary device 2040 may be a handheld computing device used by a clinician, such as a tablet, laptop, cellphone or smartphone, personal digital assistant (PDA), a wearable computer (such as a smart watch or glasses), or the like. The auxiliary device 2040 may also be simply a display device, such as a computer monitor or digital television. In an embodiment, the auxiliary device 2040 provides second screen functionality for the hub 100, PPM 102, or MMS 2004. As such, the auxiliary device 2040 can communicate wirelessly or through a wired connection with the hub 100, MMS 2004, or PPM 102.
As a second screen device, the auxiliary device 2040 can depict a copy of at least a portion of the display of the hub 100 (or the PPM 102) or a different version of the hub 100 (or the PPM 102) display. For instance, the auxiliary device 2040 can receive physiological parameter data, trend data, or waveforms from the hub 100, PPM 102, or MMS 2040 and display the parameter data, trend data, or waveforms. The auxiliary device 2040 can output any information available to the hub 100, PPM 102, or MMS 2004. One use of the auxiliary device 2040 is as a clinician device usable by a clinician to view data from the hub 100, PPM 102, or MMS 2004 while away from a patient's room (or even while in a patient's room). A clinician can use the auxiliary device 2040 to view more detailed information about physiological parameters than is displayed on the hub 100 or PPM 102 in an embodiment (see, e.g.,
One example reason for copying at least a portion of the display of the hub 100 or PPM 102 is to enable different clinicians to have the same view of the data during a surgical procedure. In some surgical procedures, for instance, two anesthesiologists monitor a patient, one anesthesiologist monitoring the brain function and brain oxygenation of the patient, while the other monitors peripheral oxygenation of the patient. A brain sensor, such as has been described above, may be attached to the patient and provide brain monitoring and oxygenation data that is output to the hub 100 or the PPM 102 for presentation to the first anesthesiologist. A finger or toe/foot optical sensor can also be attached to the patient and output data to the hub 100 or PPM 102. The hub 100 or PPM 102 can transmit this data to the auxiliary device 2040, which the second anesthesiologist can monitor to observe oxygenation in the patient's peripheral limbs. The second anesthesiologist may also need to know the oxygenation at the brain to help interpret the seriousness or lack thereof of poor peripheral oxygenation values. However, in many surgical procedures, a curtain or screen is placed over the patient as part of the procedure, blocking the second anesthesiologist's view of the hub 100 or PPM 102. Accordingly, the hub 100 or PPM 102 can output a copy of at least a portion of its display to the auxiliary device 2040 so that the second anesthesiologist can monitor brain function or oxygenation.
In one embodiment, the auxiliary device has a larger display area than the display of the hub 100. For instance, the hub 100 may have a relatively smaller display, such as about 10 inches, while the auxiliary device 2040 may be a television monitor or the like that has a 40 inch or larger display (although any size display may be used for the auxiliary device 2040). In an embodiment, the auxiliary device 2040 as a television can include a hardware module that includes a processor, memory, and a wireless or wired networking interface or the like. The processor can execute programs from the memory, including programs for displaying physiological parameters, trends, and waveforms on the display of the television. Since a television monitor is larger than embodiments of the hub 100, the television monitor version of the auxiliary device 2040 can display more fine detail of patient waveforms and trends in some embodiments (see, e.g.,
In another embodiment, the auxiliary device 2040 may display one portion of any of the displays described herein while the hub 100 displays another portion thereof. For instance, the auxiliary device 2040 may display any of the anatomical graphics described above with respect to
In still other embodiments, the auxiliary device 2040 can perform at least some processing of physiological parameters, including any of the functionality of the monitoring hub 100. For instance, the auxiliary device 2040 may include the translation module 2005 and perform the features thereof.
For example, in one embodiment, a first medical device having digital logic circuitry receives a physiological signal associated with a patient from a physiological sensor, obtains a first physiological parameter value based on the physiological signal, and outputs the first physiological parameter value for display. The first medical device can also receive a second physiological parameter value from a second medical device other than the first medical device, where the second physiological parameter value is formatted according to a protocol not used by the first medical device, such that the first medical device is not able to process the second physiological parameter value to produce a displayable output value. The first medical device can pass the physiological parameter data from the first medical device to a separate translation module, receive translated parameter data from the translation module at the first medical device, where the translated parameter data is able to be processed for display by the first medical device, and output a second value from the translated parameter data for display. The first medical device may be, for example, the hub 100, PPM 102, or MMS 2004, and the second medical device may be the infusion pump 216 or ventilator 218 or the like.
Turning to
In each of the displays of
Referring again to
IV. Translation Module Embodiments
Any of the following features described with respect to
Healthcare costs have been increasing and the demand for reasonably-priced, high-quality patient care is also on the rise. Health care costs can be reduced by increasing the effectiveness of hospital information systems. One factor which may affect the efficacy of a health institution is the extent to which the various clinical computer systems employed at the health institution can interact with one another to exchange information.
Hospitals, patient care facilities, and healthcare provider organizations typically include a wide variety of different clinical computer systems for the management of electronic healthcare information. Each of the clinical computer systems of the overall IT or management infrastructure can help fulfill a particular category or aspect of the patient care process. For example, a hospital can include patient monitoring systems, medical documentation and/or imaging systems, patient administration systems, electronic medical record systems, electronic practice management systems, business and financial systems (such as pharmacy and billing), and/or communications systems, etc.
The quality of care in a hospital or other patient care facility could be improved if each of the different clinical computer systems across the IT infrastructure (or even within the same hospital room; see, e.g.,
In current practice, individual clinical computer systems can be, and often are, provided by different vendors. As a result, individual clinical computer systems may be implemented using a proprietary network or communication infrastructure, proprietary communication protocols, etc.; the various clinical computer systems used in the hospital cannot always effectively communicate with each other.
Medical device and medical system vendors sometimes develop proprietary systems that cannot communicate effectively with medical devices and systems of other vendors in order to increase their market share and to upsell additional products, systems, and/or upgrades to the healthcare provider. Thus, healthcare providers are forced to make enterprise or system-wide purchase decisions, rather than selecting the best technology available for each type of individual clinical computer system in use.
One example where this occurs is in the area of life-saving technology available for patient monitoring. For example, many different bedside devices for monitoring various physiological parameters are available from different vendors or providers. One such provider may offer a best-in-class device for monitoring a particular physiological parameter, while another such provider may offer the best-in-class device for another physiological parameter. Accordingly, it may be desirable in some circumstances for a hospital to have the freedom to use monitoring devices from more than one manufacturer, but this may not be possible if devices from different manufacturers are incapable of interfacing and exchanging patient information. Accordingly, the ability to provide reasonably-priced, high-quality patient care can be compromised. In addition, since each hospital or patient care facility may also implement its own proprietary communication protocols for its clinical computer network environment, the exchange of information can be further hindered.
As described above, the Health Level Seven (“HL7”) protocol has been developed to provide a messaging framework for the communication of clinical messages between medical computer systems and devices. The HL7 communication protocol specifies a number of standards, guidelines, and methodologies which various HL7-compliant clinical computer systems can use to communicate with each other.
The HL7 communication protocol has been adopted by many medical device manufacturers. However, the HL7 standard is quite flexible, and merely provides a framework of guidelines (e.g., the high-level logical structure of the messages); consequently, each medical device or medical system manufacturer or vendor may implement the HL7 protocol somewhat differently while still remaining HL7-compliant. For example, the format of the HL7 messages can be different from implementation to implementation, as described more fully herein. In some cases, the HL7 messages of one implementation can also include information content that is not included in messages according to another HL7 implementation. Accordingly, medical devices or clinical computer systems that are all HL7-compliant still may be unable to communicate with each other.
Consequently, a translation module can be provided that can improve the communication of medical messages between medical devices or systems that use different allowed implementations of an established communication protocol (e.g., HL7), thereby increasing the quality of patient care through the integration of multiple clinical computer systems.
The translation module 2415 receives input messages having the first protocol format from the first medical device 2405 and generates output messages to the second medical device 2410 having the second protocol format. The translation module 2415 also receives input messages having the second protocol format from the second medical device 2410 and generates output messages to the first medical device 2405 having the first protocol format. Thus, the translation module 2415 can enable the first and second medical devices 2405, 2410 to effectively and seamlessly communicate with one another without necessarily requiring modification to the communication equipment or protocol implemented by each device.
In certain embodiments, the translation module 2415 determines the protocol format expected by an intended recipient of the input message based on, for example, the information in the input message or by referencing a database that stores the protocol format used by various devices, and then generates the output message based on the protocol format used by the intended recipient device or system. The output message can be generated based upon a comparison with, and application of, a set of translation rules 2420 that are accessible by the translation module 2415.
The translation rules 2420 can include rules that govern how to handle possible variations between formatting implementations within a common protocol. Examples of variations in formatting implementation of an electronic medical communication protocol include, for example, the delimiter or separator characters that are used to separate data fields, whether a particular field is required or optional, the repeatability of portions of the message (e.g., segments, fields, components, sub-components), the sequence of portions of the message (e.g., the order of fields or components), whether a particular portion of a message is included, the length of the message or portions of the message, and the data type used for the various portions of the message.
In certain embodiments, the translation rules 2420 define additions, deletions, swappings, and/or modifications that should be performed in order to “translate” an input message that adheres to a first HL7 implementation into an output message that adheres to a second HL7 implementation. The output message can have, for example, different formatting than the input message, while maintaining all, or a portion of, the substance or content of the input message.
In addition to translating between different implementations of a common electronic medical communication protocol (e.g., different formatting of HL7 messages), the translation module 2415 can also translate between input and output messages adhering to different communication protocols. In some embodiments, the translation module 2415 is capable of responding to and translating messages from, for example, one medical communication protocol to a separate medical communication protocol. For example, the translation module 2415 can facilitate communication between messages sent according to the HL7 protocol, the ISO 11073 protocol, other open protocols, and/or proprietary protocols. Accordingly, an input message sent according to the HL7 protocol can be translated to an output message according to a different protocol, or vice-versa.
The operation of the translation module 2415 and the translation rules 2420 will be described in more detail below. Various embodiments of system architectures including the translation module 2415 will now be described.
In certain embodiments, the first medical device 2405, the second medical device 2410, and the translation module 2415 are communicatively coupled via connection to a common communications network or directly (via cables or wirelessly), for example, through the hub 100, PPM 102, and/or MMS 2004. In some embodiments, the translation module 2415 can be communicatively coupled between the first medical device 2405 and the second medical device 2410 (with or without a communications network) such that all messages between the first and second medical devices 2405, 2410 are routed through the translation module 2415. Other architectures are also possible.
The first and second medical devices 2405, 2410 and the translation module 2415 can be included in, for example, a portion of the monitoring environments of
In certain embodiments, the translation module 2415 can facilitate communication across multiple networks within a hospital environment. In other embodiments, the translation module 2415 can facilitate communication of messages across one or more networks extending outside of the hospital or clinical network environment. For example, the translation module 2415 can provide a communications interface with banking institutions, insurance providers, government institutions, outside pharmacies, other hospitals, nursing homes, or patient care facilities, doctors' offices, and the like.
In some embodiments, the translation module 2415 of
In certain embodiments, the translation module 2415 can also facilitate communication between a first medical device that is part of the patient monitoring sub-system and a second medical device that is not part of, or is external to, the patient monitoring system 200. As such, the translation module 2415 can be capable of responding to externally-generated medical messages (such as patient information update messages, status query messages, and the like from an HIS or CIS) and generating external reporting messages (such as event reporting messages, alarm notification messages, and the like from patient monitors or nurses' monitoring stations).
In another embodiment, first and second medical devices 2405, 2410 communicate with each other over a communication bus 2421. Communication bus 2421 can include any one or more of the communication networks, systems, and methods described above, including the Internet, a hospital WLAN, a LAN, a personal area network, etc. For example, any of the networks describe above can be used to facilitate communication between a plurality of medical devices, including first and second medical devices 2405, 2410, discussed above. One such embodiment is illustrated in
In
Translation module 2415 monitors the communication bus 2421 for such messages. Translation module receives the message and determines that first medical device 2405 is attempting to communicate with second medical device 2410. Translation module 2415 determines that message translation would facilitate communication between first and second medical devices 2405, 2410. Translation module 2415 therefore utilizes an appropriate translation rule stored in a translation module 2420. Translation module 2420 can include a memory, EPROM, RAM, ROM, etc.
The translation module 2415 translates the message from the first medical device 2405 according to any of the methods described herein. Once translated, the translation module 2415 delivers the translated message to the communication bus 2421. The second medical device 2410 receives the translated message and responds appropriately. For example, the second medical device may perform a function and/or attempt to communication with the first medical device 2405. The translation module 2415 facilitates communication from the second medical device 2410 to the first medical device 2405 in a similar manner.
The first medical device 2405 and the second medical device 2410 can be, for example, any of the medical devices or systems communicatively coupled to a hospital network or hub 100, PPM 102, and/or MMS 2004. These medical devices or systems can include, for example, point-of-care devices (such as bedside patient monitors), data storage units or patient record databases, hospital or clinical information systems, central monitoring stations (such as a nurses' monitoring station), and/or clinician devices (such as pagers, cell phones, smart phones, personal digital assistants (PDAs), laptops, tablet PCs, personal computers, pods, and the like).
In some embodiments, the first medical device 2405 is a patient monitor for communicatively coupling to a patient for tracking a physiological parameter (e.g., oxygen saturation, pulse rate, blood pressure, etc.), and the second medical device 2410 is a hospital information system (“HIS”) or clinical information system (“CIS”). In some embodiments, the patient monitor can communicate physiological parameter measurements, physiological parameter alarms, or other physiological parameter measurement information generated during the monitoring of a patient to the HIS or CIS for inclusion with the patient's electronic medical records maintained by the HIS or CIS.
In some embodiments, the first medical device 2405 is an HIS or CIS and the second medical device 2410 is a nurses' monitoring station, as described herein. However, the translation module 2415 can facilitate communication between a wide variety of medical devices and systems that are used in hospitals or other patient care facilities. For example, the translation module 2415 can facilitate communication between patient physiological parameter monitoring devices, between a monitoring device and a nurses' monitoring station, etc.
Using the translation module 2415, a patient monitoring sub-system, such as those described herein (e.g., physiological monitoring system 200), can push data to the HIS or pull data from the HIS even if the HIS uses a different implementation of the HL7 protocol, or some other electronic medical communication protocol.
In certain embodiments, the patient monitoring sub-system can be configured to push/pull data at predetermined intervals. For example, a patient monitor or clinician monitoring station can download patient data automatically from the HIS at periodic intervals so that the patient data is already available when a patient is connected to a patient monitor. The patient data sent from the HIS can include admit/discharge/transfer (“ADT”) information received upon registration of the patient. ADT messages can be initiated by a hospital information system to inform ancillary systems that, for example, a patient has been admitted, discharged, transferred or registered, that patient information has been updated or merged, or that a transfer or discharge has been canceled.
In other embodiments, the patient monitoring sub-system can be configured to push/pull data to/from the HIS only when the HIS is solicited by a query. For example, a clinician may make a request for information stored in a patient's electronic medical records on the HIS.
In still other embodiments, the patient monitoring sub-system can be configured to push/pull data to/from the HIS in response to an unsolicited event. For example, a physiological parameter of a patient being monitored can enter an alarm condition, which can automatically be transmitted to the HIS for storing in the patient's electronic medical records. In yet other embodiments, any combination of the above methods or alternative methods for determining when to communicate messages to and from the HIS can be employed.
Example system architectures and example triggers for the communication of messages involving the translation module 2415 have been described. Turning now to the operation of the translation module,
In some embodiments, the message header (“MSH”) segment 2506 defines how the message is being sent, the field delimiters and encoding characters, the message type, the sender and receiver, etc. The first symbol or character after the MSH string can define the field delimiter or separator (in this message, a “caret” symbol). The next four symbols or characters can define the encoding characters. The first symbol defines the component delimiter (“˜”), the second symbol defines the repeatable delimiter (“|”), the third symbol defines the escape delimiter (“\”), and the fourth symbol defines the sub-component delimiter (“&”). All of these delimiters can vary between HL7 implementations.
In some embodiments, the example header segment 2506 further includes the sending application (“VAFC PIMS”), the receiving application (“NPTF-508”), the date/time of the message (“20091120104609-0600”), the message type (“ADT˜A01”), the message control ID (“58103”), the processing ID (“P”), and the country code (“USA”). As represented by the consecutive caret symbols, the header segment also contains multiple empty fields.
In certain embodiment, the parsed input message can be encoded.
The encoded message header segment shows some of the various data types that can be used in the message. For example, the sending application (“VAFC PIMS”) of the third parsed field and the receiving application (“NPTF-508”) of the fifth parsed field are represented using a hierarchic designator (“HD”) name data type. The date/time field (the seventh parsed field) is represented using the time stamp (“TS”) data type. The processing ID field (the eleventh parsed field) is represented using the processing type (“PT”) data type. The fields that do not include a data type identifier are represented using the string (“ST”) data type. Other possible data types include, for example, coded element, structured numeric, timing quantity, text data, date, entry identifier, coded value, numeric, and sequence identification. The data types used for the various fields or attributes of the segments can vary between formatting implementations.
Turning to the operation of the translation module, the translation module 2415 can, for example, create, generate, or produce an output message that is reflective of the input message based on an application of the set of translation rules 2420. In some embodiments, the translation module 2415 can, for example, translate, transform, convert, reformat, configure, change, rearrange, modify, adapt, alter, or adjust the input message based on a comparison with, and application of, the set of translation rules 2420 to form the output message. In some embodiments, the translation module 2415 can, for example, replace or substitute the input message with an output message that retains the content of the input message but has a new formatting implementation based upon a comparison with, and application of, the set of translation rules 2420.
At block 2604, the translation module 2415 determines the formatting implementation of the input message and the formatting implementation to be used for the output message. In certain embodiments, the input message can include one or more identifiers indicative of the formatting implementation. In some embodiments, the determination of the formatting implementation can be made, for example, by analyzing the message itself by identifying the delimiter or encoding characters used, the field order, the repeatability of segments, fields, or components, the data type of the fields, or other implementation variations. In certain embodiments, the translation module 2415 can separate or parse out the formatting from the content of the message (as shown in
In certain embodiments, the determination of the formatting implementation used by the output message can also be determined from the input message. For example, the input message can include a field that identifies the intended recipient application, facility, system, device, and/or destination. The input message can alternatively include a field that identifies the type of message being sent (e.g., ADT message) and the translation module 2415 can determine the appropriate recipient from the type of message being sent and/or the sending application, device, or system. The translation module 2415 can then determine the formatting implementation required by the intended recipient of the input message.
At decision block 2605, the translation module 2415 determines whether a rule set has been configured for the translation from the identified formatting implementation of the input message to the identified formatting implementation to be used for the output message. The rule set may have been manually configured prior to installation of the translation module software or may have been automatically configured prior to receipt of the input message. If a rule set has already been configured, then the translation process 2600 continues to block 2606. If a rule set has not been configured, then a rule set is configured at block 2607. The configuration of the rule set can be performed as described below in connection with
At block 2606, the translation module 2415 identifies the pre-configured rules from the set of translation rules 2420 that govern translation between the determined formatting implementation of the input message and the formatting implementation of the output message. In some embodiments, the identification of the pre-configured rules can be made manually.
At block 2608, the translation module 2415 generates an output message based on the configured rule set(s) of the translation rules 2420. In certain embodiments, the output message retains all, or at least a portion of, the content of the input message but has the format expected and supported by the intended recipient of the input message.
The translation rules 2420 can include, for example, unidirectional rules and/or bidirectional rules. A unidirectional rule can be one, for example, that may be applied in the case of a message from a first medical device (e.g., 2405) to a second medical device (e.g., 2410) but is not applied in the case of a message from the second medical device to the first medical device. For example, a unidirectional rule could handle a difference in the delimiters used between fields for two different formatting implementations of, for example, the HL7 communication protocol. The translation module 2415 can apply a field delimiter rule to determine if the field delimiter is supported by the intended recipient of the input message. If the field delimiter of the input message is not supported by the intended recipient, the field delimiter rule can replace the field delimiter of the input message with a field delimiter supported by the intended recipient.
For example, an input message from an input medical device can include a formatting implementation that uses a “caret” symbol (“A”) as the field delimiter or separator. However, the formatting implementation recognized by the intended recipient medical device may use a “pipe” symbol (“I”) as the field delimiter. The translation module 2415 can identify the field delimiter symbol used in the formatting implementation recognized by the intended recipient medical device from the set of translation rules 2420 and generate an output message based on the input message that uses the pipe field delimiter symbol instead of the caret field delimiter symbol used in the input message. The rule to substitute a pipe symbol for a caret symbol would, in this case, only apply to messages that are sent to a recipient device that recognizes the pipe symbol as a field delimiter. This rule could be accompanied by a complementary rule that indicates that a caret symbol should be substituted for a pipe symbol in the case of a message that is intended for a recipient device that is known to recognize the caret symbol as the field delimiter.
Another unidirectional rule can handle the presence or absence of certain fields between different formatting implementations. For example, an input message from an input medical device can include fields that would not be recognized by the intended recipient medical device. The translation module 2415 can generate an output message that does not include the unrecognized or unsupported fields. In situations where an input message does not include fields expected by the intended recipient medical device, the set of translation rules 2420 can include a rule to insert null entries or empty “ ” strings in the fields expected by the intended recipient medical device and/or to alert the recipient device of the absence of the expected field. The sender device may also be notified by the translation module 2415 that the recipient device does not support certain portions of the message.
Other unidirectional rules can facilitate, for example, the conversion of one data type to another (for example, string (“ST”) to text data (“TX”) or structured numeric (“SN”) to numeric (“NM”)), and the increase or decrease in the length of various portions of the message. Unidirectional rules can also be used to handle variations in repeatability of portions of the message. For example, the translation module 2415 can apply a field repeatability rule to repeated instances of a segment, field, component, or sub-component of the message to determine how many such repeated instances are supported by the recipient device, if any, and deleting or adding any repeated instances if necessary. For example, a phone number field of a patient identification segment can be a repeatable field to allow for entry of home, work, and cell phone numbers.
Bidirectional rules can also be used. Such rules may apply equally to messages between first and second medical devices (e.g., 2405, 2410) regardless of which device is the sender and which is the recipient. A bidirectional rule can be used to handle changes in sequence, for example. In certain implementations, an input message from an input medical device can include a patient name field, or fields, in which a first name component appears before a last name component. However, the intended recipient medical device may be expecting an implementation where the last name component appears before the first name component. Accordingly, the set of translation rules 2420 can include a bidirectional rule to swap the order of the first and last name components when communicating between the two medical devices, or between the two formatting implementations. In general, field order rules can be applied to determine whether the fields, components, or sub-components are in the correct order for the intended recipient and rearranging them if necessary. Other bidirectional rules can be included to handle, for example, other sequential variations between formatting implementations or other types of variations.
The translation rules 2420 can also include compound rules. For example, a compound rule can include an if-then sequence of rules, wherein a rule can depend on the outcome of another rule. Some translation rules 2420 may employ computations and logic (e.g., Boolean logic or fuzzy logic), etc.
As discussed above, the messages communicated over the hospital-based communication network can employ the HL7 protocol.
The translation process 2700A starts at block 2701, where the translation module 2415 receives an input message having a first HL7 format from the HIS. In certain embodiments, the input message includes information regarding, for example, the admission of a patient and/or patient identification and patient medical history information from an electronic medical records database.
At block 2703, the translation module 2415 determines the formatting implementation of the input message and the formatting implementation to be used for the output message. These determinations can be made in a similar manner to the determinations discussed above in connection with block 2604 of
At block 2705, the translation module 2415 identifies the rules that govern translation between the determined HL7 format of the input message and the HL7 format of the output message and generates an output message having the second HL7 format based on the identified rules. In certain embodiments, the output message retains the content of the input message sent by the HIS but has the format expected and supported by the intended recipient of the input message.
At block 2707, the translation module 2415 can output the output message to the intended recipient over the hospital-based communications network. In certain embodiments, the intended recipient can transmit an acknowledgement message back to the hospital information system acknowledging successful receipt or reporting that an error occurred.
The translation process 2700B starts at block 2702, where the translation module 2415 receives an input message having a first HL7 format from the medical device. In certain embodiments, the input message includes patient monitoring data or alarm data regarding one or more physiological parameters of the patient being monitored for storage in an electronic medical records database associated with the HIS.
At block 2704, the translation module 2415 determines the formatting implementation of the input message and the formatting implementation to be used for the output message. These determinations can be made in a similar manner to the determinations discussed above in connection with block 2604 of
At block 2706, the translation module 2415 identifies the rules that govern translation between the determined HL7 format of the input message and the HL7 format of the output message and generates an output message having the second HL7 format based on the identified rules. In certain embodiments, the output message retains the content of the input message sent by the medical device but has the format expected and supported by the HIS.
At block 2708, the translation module 2415 can output the output message to the hospital information system over the hospital-based communications network. In certain embodiments, the HIS can transmit an acknowledgement message back to the medical device acknowledging successful receipt or reporting that an error occurred.
The translation rules 2420 can be implemented as one or more stylesheets, hierarchical relationship data structures, tables, lists, other data structures, combinations of the same, and/or the like. In certain embodiments, the translation rules 2420 can be stored in local memory within the translation module 2415. In other embodiments, the translation rules 2420 can be stored in external memory or on a data storage device communicatively coupled to the translation module 2415.
The translation module 2415 can include a single rule set or multiple rule sets. For example, the translation module 2415 can include a separate rule set for each medical device/system and/or for each possible communication pair of medical devices/systems coupled to the network or capable of being coupled to the network. In some embodiments, the translation module 2415 can include a separate rule set for each possible pair of formatting implementations that are allowed under a medical communication protocol such as, for example, the HL7 protocol.
In certain embodiments, the translation rules 2420 can be manually inputted using, for example, the messaging implementation software tool 2800 illustrated in
In other embodiments, the translation rules 2420 can be automatically generated. For example, the automatic generation of a new set, or multiple sets, of rules can be triggered by the detection of a newly recognized “communicating” medical device or system on a network. In certain embodiments, the automatic generation of a new set or multiple sets of rules can occur at the time a first message is received from or sent to a new “communicating” medical device or system coupled to the network. In still other embodiments, the automatic generation of rule sets includes updating or dynamically modifying a pre-existing set of rules.
The automatic generation of translation rule sets can be carried out in a variety of ways. For example, in some embodiments, the translation module 2415 can automatically initiate usage of a pre-configured set of translation rules 2420 based upon, for example, the make and model of a new device that is recognized on the network. In certain embodiments, the translation module 2415 can request one or more messages from the new device or system and then analyze the messages to determine the type of formatting being implemented, as illustrated by the automatic rule configuration process 2900A of
At block 2903, the translation module 2415 determines the protocol of the one or more received messages by, for example, analyzing the message or by consulting a database that indicates what communication protocol/format is implemented by each medical device or system on the network. In certain embodiments, the translation module 2415 is configured to handle medical messages implemented using a single common protocol, such as HL7. Accordingly, if a determination is made that the received messages are implemented using a non-supported or non-recognized protocol, the translation module can ignore the messages received from the detected medical device or system, output an alert or warning, or allow the messages to be sent without being translated.
At block 2905, the translation module 2415 determines the formatting implementation of the received message(s). In certain embodiments, the received messages can include one or more identifiers indicative of the formatting implementation. In other embodiments, the determination of the formatting implementation can be made, for example, by analyzing the message itself by checking field order, the delimiter or encoding characters used, or other implementation variations. In certain embodiments, the translation module 2415 can separate or parse out the formatting from the content of the message to aid in the determination of the formatting implementation.
At block 2907, the translation module 2415 configures one or more rules or rule sets to handle messages received from and/or sent to the detected medical device or system. In certain embodiments, the configuration of the rules involves the creation or generation of new rules. In other embodiments, the configuration of the rules involves the alteration or updating of existing rules. The configured rules or rule sets can be included with the translation rules 2420. If a set of rules already exists for the formatting implementation used by the new device or system, then the configuration of new translation rules may not be required. Instead, existing translation rules can be associated with the new device or system for use in communication involving that device or system. In other embodiments, the translation module 2415 can create a new set of rules geared specifically for the new device or system or can modify an existing set of rules based on subtle formatting variations identified.
In other embodiments, the translation module 2415 can generate test message(s) that may be useful in identifying the communication protocol and implementation used by a device or system. For example, the translation module can generate test messages to cause the newly detected device or system to take a particular action (e.g., store information) and then query information regarding the action taken by the newly detected device to determine whether or how the test message was understood. This is illustrated by the automatic rule configuration process 2900B of
The automatic rule configuration process 2900B starts at block 2902, where the translation module 2415 transmits one or more test, or initialization, messages to a remote device or system detected on a network. The test messages can be configured, for example, to instruct the remote device or system to take a particular action (e.g., store patient information). In certain embodiments, the test messages can be configured to generate a response indicative of the type of formatting recognized or supported by the remote device or system. In other embodiments, the test messages can be configured such that only devices or systems supporting a particular formatting implementation will understand and properly act on the test messages.
At block 2904, the translation module 2415 queries the remote device or system to receive information regarding the action taken based on the test message sent to the remote device or system to determine whether the test message was understood. For example, if the test message instructed the remote device or system to store patient information in a particular location, the translation module 2415 can query the information from the location to determine whether the test message was understood. If the test message was not understood, the translation module 2415 can, for example, continue sending test messages of known formatting implementations until a determination is made that the test message has been understood.
At block 2906, the translation module 2415 determines the protocol and formatting implementation based on the information received. As an example, in certain embodiments, the test message can include an instruction to store patient name information. The test message can include a patient name field having a first name component followed by a surname component. The translation module 2415 can then query the remote device or system to return the patient surname. Depending on whether the patient surname or the first name is returned, this query can be useful in determining information about the order of fields in the formatting implementation being used by the remote device or system. As another example, the test messages can instruct the detected device or system to store repeated instances of a component. The translation module 2415 can then query the device or system to return the repeated instances to see which, if any, were stored. This repeatability information can also be useful in determining whether certain fields are allowed to be repeated in the formatting implementation being used by the remote device for system, and, if so, how many repeated instances are permitted.
At block 2908, the translation module 2415 configures one or more rules to handle messages received from and/or sent to the detected medical device or system. For example, the rules can convert messages from the message format used by a first medical device to that used by a second medical device, as described herein. In certain embodiments, the configuration of the rules involves the creation or generation of new rules. In other embodiments, the configuration of the rules involves the alteration or updating of existing rules. If a set of rules already exists for the formatting implementation used by the new device or system, then the configuration of new translation rules may not be required. Instead, existing translation rules can be associated with the new device or system for use in communication involving that device or system.
The automatic rule configuration process 2900C illustrated in
At block 2917, the translation module 2415 configures one or more rules to handle messages received from and/or sent to the HL7 medical device. In certain embodiments, the configuration of the rules involves the creation or generation of new rules for the detected formatting implementation. In other embodiments, the configuration of the rules involves the dynamic alteration or updating of existing rules. If a set of rules already exists for the formatting implementation used by the new HL7 medical device, then the configuration of new translation rules may not be required. Instead, existing translation rules can be associated with the new HL7 medical device for use in communication involving that device.
The automatic rule configuration process 2900D illustrated in
At block 2914, the translation module 2415 queries the HL7 medical device to receive information regarding an action taken or information stored in response to the test message. At block 2916, the translation module 2415 determines the formatting implementation of the HL7 device based on the information received. In certain embodiments, the translation module 2415 can analyze the information received to determine whether the test message or messages were properly understood. If none of the test messages were properly understood, the translation module 2415 can send additional test messages having other known HL7 formats and repeat blocks 2914 and 2916.
At block 2918, the translation module 2415 configures one or more translation rules to handle messages received from and/or sent to the detected HL7 medical device. In certain embodiments, the configuration of the translation rules involves the creation or generation of new translation rules. In other embodiments, the configuration of the rules involves the alteration or updating of existing rules. If a set of translation rules already exists for the formatting implementation used by the new HL7 medical device, then the configuration of new translation rules may not be required. Instead, existing translation rules can be associated with the new HL7 medical device for use in communication involving that HL7 medical device.
The automatic rule configuration processes described above can be triggered by the detection of a network device or system by the translation module 2415. The medical devices referred to in
In some embodiments, the automatic generation of translation rules can advantageously occur post-installation and post-compilation of the messaging sub-system software, which includes the translation module 2415. In certain embodiments, the automatic generation or dynamic modification of the translation rules 2420 can occur without having to recompile or rebuild the translation module software. This feature can be advantageous in terms of efficiently complying with U.S. Food and Drug Administration (“FDA”) requirements regarding validation of software used in healthcare environments.
Take, for example, a situation where a medical device manufacturer plans to use the translation module 2415 to facilitate communication between a particular medical device or system that is to be installed in a hospital (e.g., a patient monitoring system, as described herein), or other patient care facility, and other devices or systems that are already installed at the hospital (e.g., the HIS or CIS). Any software required for the operation of the new medical device to be installed may be at least partially validated for FDA compliance prior to installation at the hospital despite the fact that, for example, the HL7 implementations of other existing devices or systems at the hospital may still be unknown. For example, any aspects of the software for the new medical device that are dependent upon receiving messages from other hospital devices can be validated pre-installation as being capable of fully and correctly operating when the expected message format is received. Then, once the medical device is installed at the hospital, the validation of the software can be completed by showing that the translation module 2415 is able to provide messages of the expected format to the newly installed device. In this way, FDA validation tasks can be apportioned to a greater extent to the pre-installation timeframe where they can be more easily carried out in a controlled manner rather than in the field.
In addition, the translation module 2415 can further help streamline FDA validation, for example, when a medical device or system is expected to be installed at different hospitals whose existing devices use, for example, different implementations of the HL7 protocol. Normally, this type of situation could impose the requirement that the entire functionality of the software for the new medical device be completely validated at each hospital. However, if the translation module 2415 is used to interface between the new medical device and the hospital's existing devices, then much of the software functionality could possibly be validated a single time prior to installation, as just described. Then, once installed at each hospital, the software validation for the medical device can be completed by validating that correct message formats are received from the translation module (the translation rules for which are field-customizable). This may result in making on-site validation procedures significantly more efficient, which will advantageously enable more efficient FDA compliance in order to bring life-saving medical technology to patients more quickly by the use of field-customizable translation rules.
V. Example Embodiments
In certain embodiments, a system for providing medical data translation for output on a medical monitoring hub can include a portable physiological monitor comprising a processor that can: receive a physiological signal associated with a patient from a physiological sensor, calculate a physiological parameter based on the physiological signal, and provide a first value of the physiological parameter to a monitoring hub for display. The monitoring hub can include a docking station that can receive the portable physiological monitor. The monitoring hub can: receive the first value of the physiological parameter from the portable physiological monitor; output the first value of the physiological parameter for display; receive physiological parameter data from a medical device other than the portable physiological monitor, the physiological parameter data formatted according to a protocol other than a protocol natively readable or displayable by the monitoring hub; pass the physiological parameter data to a translation module; receive translated parameter data from the translation module, where the translated parameter data can be readable and displayable by the monitoring hub; and output a second value from the translated parameter data for display.
The system of the preceding paragraph can be combined with any subcombination of the following features: the monitoring hub is further configured to output the first value of the physiological parameter and the second value from the translated parameter data on separate displays; the monitoring hub is further configured to output the second value from the translated parameter data to an auxiliary device having a separate display from a display of the monitoring hub; the auxiliary device is selected from the group consisting of a television, a tablet, a phone, a wearable computer, and a laptop; the physiological parameter data comprises data from an infusion pump; the physiological parameter data comprises data from a ventilator; and the translation module is configured to translate the physiological parameter data from a first Health Level 7 (HL7) format to a second HL7 format.
In certain embodiments, a method of providing medical data translation for output on a medical monitoring hub can include: under the control of a first medical device comprising digital logic circuitry, receiving a physiological signal associated with a patient from a physiological sensor; obtaining a first physiological parameter value based on the physiological signal; outputting the first physiological parameter value for display; receiving a second physiological parameter value from a second medical device other than the first medical device, where the second physiological parameter value is formatted according to a protocol not used by the first medical device, such that the first medical device is not able to process the second physiological parameter value to produce a displayable output value; passing the physiological parameter data from the first medical device to a separate translation module; receiving translated parameter data from the translation module at the first medical device, the translated parameter data able to be processed for display by the first medical device; and outputting a second value from the translated parameter data for display.
The method of the preceding paragraph can be combined with any subcombination of the following features: further including translating the message by at least translating the message from a first Health Level 7 (HL7) format to a second HL7 format; the message can include data from a physiological monitor; the message can include data from an infusion pump or a ventilator; and the message can include data from a hospital bed.
In certain embodiments, a system for providing medical data translation for output on a medical monitoring hub can include a first medical device including electronic hardware that can: obtain a first physiological parameter value associated with a patient; output the first physiological parameter value for display; receive a second physiological parameter value from a second medical device other than the first medical device, the second physiological parameter value formatted according to a protocol not used by the first medical device, such that the first medical device is not able to process the second physiological parameter value to produce a displayable output value; pass the physiological parameter data from the first medical device to a translation module; receive translated parameter data from the translation module at the first medical device, the translated parameter data able to be processed for display by the first medical device; and output a second value from the translated parameter data for display.
The system of the preceding paragraph can be combined with any subcombination of the following features: the first medical device can also output the first value of the physiological parameter and the second value from the translated parameter data on the same display; the first medical device can also output the first value of the physiological parameter and the second value from the translated parameter data on separate displays; the first medical device can also output the second value from the translated parameter data to an auxiliary device; the auxiliary device can be a television monitor; the auxiliary device can be selected from the group consisting of a tablet, a phone, a wearable computer, and a laptop; the first medical device can include the translation module; the first medical device can also pass the physiological parameter data to the translation module over a network; and the physiological parameter data can include data from an infusion pump or a ventilator.
VI. Terminology
Many other variations than those described herein will be apparent from this disclosure. For example, depending on the embodiment, certain acts, events, or functions of any of the algorithms described herein can be performed in a different sequence, can be added, merged, or left out altogether (e.g., not all described acts or events are necessary for the practice of the algorithms). Moreover, in certain embodiments, acts or events can be performed concurrently, e.g., through multi-threaded processing, interrupt processing, or multiple processors or processor cores or on other parallel architectures, rather than sequentially. In addition, different tasks or processes can be performed by different machines and/or computing systems that can function together.
It is to be understood that not necessarily all such advantages can be achieved in accordance with any particular embodiment of the embodiments disclosed herein. Thus, the embodiments disclosed herein can be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein.
The various illustrative logical blocks, modules, and algorithm steps described in connection with the embodiments disclosed herein can be implemented as electronic hardware, computer software, or combinations of both. To clearly illustrate this interchangeability of hardware and software, various illustrative components, blocks, modules, and steps have been described above generally in terms of their functionality. Whether such functionality is implemented as hardware or software depends upon the particular application and design constraints imposed on the overall system. The described functionality can be implemented in varying ways for each particular application, but such implementation decisions should not be interpreted as causing a departure from the scope of the disclosure.
The various illustrative logical blocks and modules described in connection with the embodiments disclosed herein can be implemented or performed by a machine, such as a general purpose processor, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA) or other programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof designed to perform the functions described herein. A general purpose processor can be a microprocessor, but in the alternative, the processor can be a controller, microcontroller, or state machine, combinations of the same, or the like. A processor can include electrical circuitry or digital logic circuitry configured to process computer-executable instructions. In another embodiment, a processor includes an FPGA or other programmable device that performs logic operations without processing computer-executable instructions. A processor can also be implemented as a combination of computing devices, e.g., a combination of a DSP and a microprocessor, a plurality of microprocessors, one or more microprocessors in conjunction with a DSP core, or any other such configuration. A computing environment can include any type of computer system, including, but not limited to, a computer system based on a microprocessor, a mainframe computer, a digital signal processor, a portable computing device, a device controller, or a computational engine within an appliance, to name a few.
The steps of a method, process, or algorithm described in connection with the embodiments disclosed herein can be embodied directly in hardware, in a software module stored in one or more memory devices and executed by one or more processors, or in a combination of the two. A software module can reside in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, hard disk, a removable disk, a CD-ROM, or any other form of non-transitory computer-readable storage medium, media, or physical computer storage known in the art. An example storage medium can be coupled to the processor such that the processor can read information from, and write information to, the storage medium. In the alternative, the storage medium can be integral to the processor. The storage medium can be volatile or nonvolatile. The processor and the storage medium can reside in an ASIC.
Conditional language used herein, such as, among others, “can,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements and/or states. Thus, such conditional language is not generally intended to imply that features, elements and/or states are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without author input or prompting, whether these features, elements and/or states are included or are to be performed in any particular embodiment. The terms “comprising,” “including,” “having,” and the like are synonymous and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and so forth. Also, the term “or” is used in its inclusive sense (and not in its exclusive sense) so that when used, for example, to connect a list of elements, the term “or” means one, some, or all of the elements in the list. Further, the term “each,” as used herein, in addition to having its ordinary meaning, can mean any subset of a set of elements to which the term “each” is applied.
Disjunctive language such as the phrase “at least one of X, Y, or Z,” unless specifically stated otherwise, is otherwise understood with the context as used in general to present that an item, term, etc., may be either X, Y, or Z, or any combination thereof (e.g., X, Y, and/or Z). Thus, such disjunctive language is not generally intended to, and should not, imply that certain embodiments require at least one of X, at least one of Y, or at least one of Z to each be present.
Unless otherwise explicitly stated, articles such as “a” or “an” should generally be interpreted to include one or more described items. Accordingly, phrases such as “a device configured to” are intended to include one or more recited devices. Such one or more recited devices can also be collectively configured to carry out the stated recitations. For example, “a processor configured to carry out recitations A, B and C” can include a first processor configured to carry out recitation A working in conjunction with a second processor configured to carry out recitations B and C.
While the above detailed description has shown, described, and pointed out novel features as applied to various embodiments, it will be understood that various omissions, substitutions, and changes in the form and details of the devices or algorithms illustrated can be made without departing from the spirit of the disclosure. As will be recognized, certain embodiments of the inventions described herein can be embodied within a form that does not provide all of the features and benefits set forth herein, as some features can be used or practiced separately from others.
Additionally, all publications, patents, and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference.
This application is a continuation of U.S. application Ser. No. 15/919,792, filed Mar. 13, 2018, titled “System for Displaying Medical Monitoring Data,” which application is a continuation of U.S. application Ser. No. 14/512,237, filed Oct. 10, 2014, titled “System for Displaying Medical Monitoring Data,” which application is a non-provisional of U.S. Provisional Application No. 61/889,972, filed Oct. 11, 2013, titled “System for Displaying Medical Monitoring Data,” and is also a continuation-in-part of U.S. application Ser. No. 13/651,167, filed Oct. 12, 2012, titled “Medical Monitoring Hub,” which is a non-provisional of each of the following U.S. Provisional Patent Applications: Ser. No.DateTitle61/547,017,Oct. 13, 2011,Visual Correlation of PhysiologicalInformation,61/547,577,Oct. 14, 2011,Visual Correlation of PhysiologicalInformation,61/597,120,Feb. 9, 2012,Visual Correlation of PhysiologicalInformation,61/703,773,Sep. 20, 2012,Medical Monitoring Hub All of the above applications are incorporated by reference herein in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3646606 | Buxton et al. | Feb 1972 | A |
3690313 | Weppner et al. | Sep 1972 | A |
3810102 | Parks, III et al. | May 1974 | A |
3815583 | Scheidt | Jun 1974 | A |
3972320 | Kalman | Aug 1976 | A |
3978849 | Geneen | Sep 1976 | A |
4108166 | Schmid | Aug 1978 | A |
4231354 | Kurtz et al. | Nov 1980 | A |
4589415 | Haag | May 1986 | A |
4662378 | Thomis | May 1987 | A |
4838275 | Lee | Jun 1989 | A |
4852570 | Levine | Aug 1989 | A |
4960128 | Gordon et al. | Oct 1990 | A |
4964408 | Hink et al. | Oct 1990 | A |
5041187 | Hink et al. | Aug 1991 | A |
5069213 | Polczynski | Dec 1991 | A |
5092340 | Yamaguchi et al. | Mar 1992 | A |
5140519 | Friesdorf et al. | Aug 1992 | A |
5159932 | Zanetti et al. | Nov 1992 | A |
5161539 | Evans et al. | Nov 1992 | A |
5163438 | Gordon et al. | Nov 1992 | A |
5262944 | Weisner et al. | Nov 1993 | A |
5277189 | Jacobs | Jan 1994 | A |
5278627 | Aoyagi et al. | Jan 1994 | A |
5282474 | Valdes Sosa et al. | Feb 1994 | A |
5296688 | Hamilton et al. | Mar 1994 | A |
5307263 | Brown | Apr 1994 | A |
5309918 | Schraag | May 1994 | A |
5318037 | Evans et al. | Jun 1994 | A |
5319355 | Russek | Jun 1994 | A |
5331549 | Crawford, Jr. | Jul 1994 | A |
5333106 | Lanpher et al. | Jul 1994 | A |
5337744 | Branigan | Aug 1994 | A |
5341805 | Stavridi et al. | Aug 1994 | A |
5348008 | Bornn et al. | Sep 1994 | A |
5358519 | Grandjean | Oct 1994 | A |
D353195 | Savage et al. | Dec 1994 | S |
D353196 | Savage et al. | Dec 1994 | S |
5375599 | Shimizu | Dec 1994 | A |
5375604 | Kelly et al. | Dec 1994 | A |
5377676 | Vari et al. | Jan 1995 | A |
5390238 | Kirk et al. | Feb 1995 | A |
5400794 | Gorman | Mar 1995 | A |
5406952 | Barnes et al. | Apr 1995 | A |
D357982 | Dahl et al. | May 1995 | S |
5416695 | Stutman et al. | May 1995 | A |
5420606 | Begum et al. | May 1995 | A |
D359546 | Savage et al. | Jun 1995 | S |
5431170 | Mathews | Jul 1995 | A |
5434611 | Tamura | Jul 1995 | A |
5436499 | Namavar et al. | Jul 1995 | A |
D361840 | Savage et al. | Aug 1995 | S |
D362063 | Savage et al. | Sep 1995 | S |
5452717 | Branigan et al. | Sep 1995 | A |
D363120 | Savage et al. | Oct 1995 | S |
5456252 | Vari et al. | Oct 1995 | A |
5477146 | Jones | Dec 1995 | A |
5479934 | Imran | Jan 1996 | A |
5482036 | Diab et al. | Jan 1996 | A |
5483968 | Adam et al. | Jan 1996 | A |
5490505 | Diab et al. | Feb 1996 | A |
5494041 | Wilk | Feb 1996 | A |
5494043 | O'Sullivan et al. | Feb 1996 | A |
5503149 | Beavin | Apr 1996 | A |
5505202 | Mogi et al. | Apr 1996 | A |
5533511 | Kaspari et al. | Jul 1996 | A |
5534851 | Russek | Jul 1996 | A |
5537289 | Dahl | Jul 1996 | A |
5544649 | David et al. | Aug 1996 | A |
5553609 | Chen et al. | Sep 1996 | A |
5558638 | Evers et al. | Sep 1996 | A |
5561275 | Savage et al. | Oct 1996 | A |
5562002 | Lalin | Oct 1996 | A |
5566676 | Rosenfeldt et al. | Oct 1996 | A |
5576952 | Stutman et al. | Nov 1996 | A |
5579001 | Dempsey et al. | Nov 1996 | A |
5590649 | Caro et al. | Jan 1997 | A |
5602924 | Durand et al. | Feb 1997 | A |
5619991 | Sloane | Apr 1997 | A |
5632272 | Diab et al. | May 1997 | A |
5638816 | Kiani-Azarbayjany et al. | Jun 1997 | A |
5638818 | Diab et al. | Jun 1997 | A |
5640953 | Bishop et al. | Jun 1997 | A |
5640967 | Fine et al. | Jun 1997 | A |
5645440 | Tobler et al. | Jul 1997 | A |
5651368 | Napolitano | Jul 1997 | A |
5671914 | Kalkhoran et al. | Sep 1997 | A |
5685299 | Diab et al. | Nov 1997 | A |
5685314 | Geheb et al. | Nov 1997 | A |
5687717 | Halpern et al. | Nov 1997 | A |
5687732 | Inagaki | Nov 1997 | A |
5694020 | Lang et al. | Dec 1997 | A |
5724580 | Levin et al. | Mar 1998 | A |
5724983 | Selker et al. | Mar 1998 | A |
5725308 | Smith et al. | Mar 1998 | A |
5726440 | Kalkhoran et al. | Mar 1998 | A |
5734739 | Sheehan et al. | Mar 1998 | A |
D393830 | Tobler et al. | Apr 1998 | S |
5743262 | Lepper, Jr. et al. | Apr 1998 | A |
5747806 | Khalil et al. | May 1998 | A |
5750994 | Schlager | May 1998 | A |
5758079 | Ludwig et al. | May 1998 | A |
5758644 | Diab et al. | Jun 1998 | A |
5760910 | Lepper, Jr. et al. | Jun 1998 | A |
5769785 | Diab et al. | Jun 1998 | A |
5772585 | Lavin et al. | Jun 1998 | A |
5772586 | Heinonen et al. | Jun 1998 | A |
5782757 | Diab et al. | Jul 1998 | A |
5782805 | Meinzer | Jul 1998 | A |
5785659 | Caro et al. | Jul 1998 | A |
5791347 | Flaherty et al. | Aug 1998 | A |
5801637 | Lomholt | Sep 1998 | A |
5810734 | Caro et al. | Sep 1998 | A |
5813403 | Seller et al. | Sep 1998 | A |
5822544 | Chaco et al. | Oct 1998 | A |
5822546 | George | Oct 1998 | A |
5823950 | Diab et al. | Oct 1998 | A |
5829723 | Brunner | Nov 1998 | A |
5830131 | Caro et al. | Nov 1998 | A |
5833618 | Caro et al. | Nov 1998 | A |
5855550 | Lai et al. | Jan 1999 | A |
5860919 | Kiani-Azarbayjany et al. | Jan 1999 | A |
5876351 | Rohde | Mar 1999 | A |
5885214 | Monroe et al. | Mar 1999 | A |
5890929 | Mills et al. | Apr 1999 | A |
5895359 | Peel, III | Apr 1999 | A |
5904654 | Wohltmann et al. | May 1999 | A |
5910139 | Cochran et al. | Jun 1999 | A |
5919134 | Diab | Jul 1999 | A |
5921920 | Marshall et al. | Jul 1999 | A |
5924074 | Evans | Jul 1999 | A |
5931160 | Gilmore et al. | Aug 1999 | A |
5931791 | Saltzstein et al. | Aug 1999 | A |
5934925 | Tobler et al. | Aug 1999 | A |
5940182 | Lepper, Jr. et al. | Aug 1999 | A |
5942986 | Shabot et al. | Aug 1999 | A |
5987343 | Kinast | Nov 1999 | A |
5987519 | Peifer et al. | Nov 1999 | A |
5995855 | Kiani et al. | Nov 1999 | A |
5997343 | Mills et al. | Dec 1999 | A |
6002952 | Diab et al. | Dec 1999 | A |
6006119 | Seller et al. | Dec 1999 | A |
6010937 | Karam et al. | Jan 2000 | A |
6011986 | Diab et al. | Jan 2000 | A |
6014346 | Malone | Jan 2000 | A |
6018673 | Chin et al. | Jan 2000 | A |
6024699 | Surwit et al. | Feb 2000 | A |
6027452 | Flaherty et al. | Feb 2000 | A |
6032678 | Rottem | Mar 2000 | A |
6035230 | Kang et al. | Mar 2000 | A |
6036642 | Diab et al. | Mar 2000 | A |
6036718 | Ledford et al. | Mar 2000 | A |
6040578 | Malin et al. | Mar 2000 | A |
6045509 | Caro et al. | Apr 2000 | A |
6045527 | Appelbaum et al. | Apr 2000 | A |
6057758 | Dempsey et al. | May 2000 | A |
6066204 | Haven | May 2000 | A |
6067462 | Diab et al. | May 2000 | A |
6081735 | Diab et al. | Jun 2000 | A |
6088607 | Diab et al. | Jul 2000 | A |
6093146 | Filangeri | Jul 2000 | A |
6101478 | Brown | Aug 2000 | A |
6106463 | Wilk | Aug 2000 | A |
6110522 | Lepper, Jr. et al. | Aug 2000 | A |
6115673 | Malin et al. | Sep 2000 | A |
6124597 | Shehada | Sep 2000 | A |
6128521 | Marro et al. | Oct 2000 | A |
6129675 | Jay | Oct 2000 | A |
6132218 | Benja-Athon | Oct 2000 | A |
6139494 | Cairnes | Oct 2000 | A |
6144868 | Parker | Nov 2000 | A |
6151516 | Kiani-Azarbayjany et al. | Nov 2000 | A |
6152754 | Gerhardt et al. | Nov 2000 | A |
6157850 | Diab et al. | Dec 2000 | A |
6165005 | Mills et al. | Dec 2000 | A |
6167258 | Schmidt et al. | Dec 2000 | A |
D437058 | Gozani | Jan 2001 | S |
6168563 | Brown | Jan 2001 | B1 |
6171237 | Avitall et al. | Jan 2001 | B1 |
6175752 | Say et al. | Jan 2001 | B1 |
6183417 | Gehab et al. | Feb 2001 | B1 |
6184521 | Coffin, IV et al. | Feb 2001 | B1 |
6185448 | Borovsky | Feb 2001 | B1 |
6195576 | John | Feb 2001 | B1 |
6206830 | Diab et al. | Mar 2001 | B1 |
6221012 | Maschke et al. | Apr 2001 | B1 |
6224553 | Nevo | May 2001 | B1 |
6229856 | Diab et al. | May 2001 | B1 |
6230142 | Benigno et al. | May 2001 | B1 |
6232609 | Snyder et al. | May 2001 | B1 |
6236872 | Diab et al. | May 2001 | B1 |
6241683 | Macklem et al. | Jun 2001 | B1 |
6241684 | Amano et al. | Jun 2001 | B1 |
6251113 | Appelbaum | Jun 2001 | B1 |
6253097 | Aronow et al. | Jun 2001 | B1 |
6255708 | Sudharsanan et al. | Jul 2001 | B1 |
6256523 | Diab et al. | Jul 2001 | B1 |
6263222 | Diab et al. | Jul 2001 | B1 |
6267723 | Matsumura et al. | Jul 2001 | B1 |
6269262 | Kandori et al. | Jul 2001 | B1 |
6278522 | Lepper, Jr. et al. | Aug 2001 | B1 |
6280213 | Tobler et al. | Aug 2001 | B1 |
6280381 | Malin et al. | Aug 2001 | B1 |
6285896 | Tobler et al. | Sep 2001 | B1 |
6301493 | Marro et al. | Oct 2001 | B1 |
6304767 | Seller et al. | Oct 2001 | B1 |
6308089 | von der Ruhr et al. | Oct 2001 | B1 |
6312378 | Bardy | Nov 2001 | B1 |
6317627 | Ennen et al. | Nov 2001 | B1 |
6321100 | Parker | Nov 2001 | B1 |
6322502 | Schoenberg et al. | Nov 2001 | B1 |
6325761 | Jay | Dec 2001 | B1 |
6329139 | Nova et al. | Dec 2001 | B1 |
6334065 | Al-Ali et al. | Dec 2001 | B1 |
6338039 | Lonski et al. | Jan 2002 | B1 |
6343224 | Parker | Jan 2002 | B1 |
6344025 | Inagaki et al. | Feb 2002 | B1 |
6349228 | Kiani et al. | Feb 2002 | B1 |
6352504 | Ise | Mar 2002 | B1 |
6354235 | Davies | Mar 2002 | B1 |
6360114 | Diab et al. | Mar 2002 | B1 |
6364834 | Reuss et al. | Apr 2002 | B1 |
6364839 | Little et al. | Apr 2002 | B1 |
6368283 | Xu et al. | Apr 2002 | B1 |
6371921 | Caro et al. | Apr 2002 | B1 |
6377829 | Al-Ali | Apr 2002 | B1 |
6385476 | Osadchy et al. | May 2002 | B1 |
6385589 | Trusheim et al. | May 2002 | B1 |
6388240 | Schulz et al. | May 2002 | B2 |
6397091 | Diab et al. | May 2002 | B2 |
6407335 | Franklin-Lees | Jun 2002 | B1 |
6411373 | Garside et al. | Jun 2002 | B1 |
6415167 | Blank et al. | Jul 2002 | B1 |
6430437 | Marro | Aug 2002 | B1 |
6430525 | Weber et al. | Aug 2002 | B1 |
6463311 | Diab | Oct 2002 | B1 |
6470199 | Kopotic et al. | Oct 2002 | B1 |
6470893 | Boesen | Oct 2002 | B1 |
6487429 | Hockersmith et al. | Nov 2002 | B2 |
6501975 | Diab et al. | Dec 2002 | B2 |
6505059 | Kollias et al. | Jan 2003 | B1 |
6515273 | Al-Ali | Feb 2003 | B2 |
6516289 | David et al. | Feb 2003 | B2 |
6519487 | Parker | Feb 2003 | B1 |
6524240 | Thede | Feb 2003 | B1 |
6525386 | Mills et al. | Feb 2003 | B1 |
6526300 | Kiani et al. | Feb 2003 | B1 |
6534012 | Hazen et al. | Mar 2003 | B1 |
6541756 | Schulz et al. | Apr 2003 | B2 |
6542764 | Al-Ali et al. | Apr 2003 | B1 |
6544173 | West et al. | Apr 2003 | B2 |
6544174 | West et al. | Apr 2003 | B2 |
6551243 | Bocionek et al. | Apr 2003 | B2 |
6570592 | Sajdak et al. | May 2003 | B1 |
6578428 | Dromms et al. | Jun 2003 | B1 |
6580086 | Schulz et al. | Jun 2003 | B1 |
6584336 | Ali et al. | Jun 2003 | B1 |
6587196 | Stippick et al. | Jul 2003 | B1 |
6587199 | Luu | Jul 2003 | B1 |
6595316 | Cybulski et al. | Jul 2003 | B2 |
6597932 | Tian et al. | Jul 2003 | B2 |
6597933 | Kiani et al. | Jul 2003 | B2 |
6606511 | Ali et al. | Aug 2003 | B1 |
6616606 | Peterson et al. | Sep 2003 | B1 |
6632181 | Flaherty et al. | Oct 2003 | B2 |
6635559 | Greenwald et al. | Oct 2003 | B2 |
6639668 | Trepagnier | Oct 2003 | B1 |
6640116 | Diab | Oct 2003 | B2 |
6640117 | Makarewicz et al. | Oct 2003 | B2 |
6641533 | Causey et al. | Nov 2003 | B2 |
6643530 | Diab et al. | Nov 2003 | B2 |
6646556 | Smith et al. | Nov 2003 | B1 |
6650917 | Diab et al. | Nov 2003 | B2 |
6650939 | Takpke, II et al. | Nov 2003 | B2 |
6654624 | Diab et al. | Nov 2003 | B2 |
D483872 | Cruz et al. | Dec 2003 | S |
6658276 | Kianl et al. | Dec 2003 | B2 |
6661161 | Lanzo et al. | Dec 2003 | B1 |
6663570 | Mott et al. | Dec 2003 | B2 |
6671531 | Al-Ali et al. | Dec 2003 | B2 |
6678543 | Diab et al. | Jan 2004 | B2 |
6684090 | Ali et al. | Jan 2004 | B2 |
6684091 | Parker | Jan 2004 | B2 |
6694180 | Boesen | Feb 2004 | B1 |
6697656 | Al-Ali | Feb 2004 | B1 |
6697657 | Shehada et al. | Feb 2004 | B1 |
6697658 | Al-Ali | Feb 2004 | B2 |
RE38476 | Diab et al. | Mar 2004 | E |
6699194 | Diab et al. | Mar 2004 | B1 |
6707476 | Hochstedler | Mar 2004 | B1 |
6714804 | Al-Ali et al. | Mar 2004 | B2 |
RE38492 | Diab et al. | Apr 2004 | E |
6719694 | Weng et al. | Apr 2004 | B2 |
6721582 | Trepagnier et al. | Apr 2004 | B2 |
6721585 | Parker | Apr 2004 | B1 |
6725075 | Al-Ali | Apr 2004 | B2 |
6725086 | Marinello | Apr 2004 | B2 |
6728560 | Kollias et al. | Apr 2004 | B2 |
6735459 | Parker | May 2004 | B2 |
6738652 | Mattu et al. | May 2004 | B2 |
6745060 | Diab et al. | Jun 2004 | B2 |
6746406 | Lia et al. | Jun 2004 | B2 |
6749566 | Russ | Jun 2004 | B2 |
6750463 | Riley | Jun 2004 | B1 |
6751492 | Ben-haim | Jun 2004 | B2 |
6760607 | Al-Ali | Jul 2004 | B2 |
6766188 | Soller | Jul 2004 | B2 |
6770028 | Ali et al. | Aug 2004 | B1 |
6771994 | Kiani et al. | Aug 2004 | B2 |
6773396 | Flach et al. | Aug 2004 | B2 |
6783492 | Dominguez | Aug 2004 | B2 |
6788965 | Ruchti et al. | Sep 2004 | B2 |
6790178 | Mault et al. | Sep 2004 | B1 |
6792300 | Diab et al. | Sep 2004 | B1 |
6795724 | Hogan | Sep 2004 | B2 |
6796186 | Lia et al. | Sep 2004 | B2 |
6804656 | Rosenfeld | Oct 2004 | B1 |
6807050 | Whitehorn et al. | Oct 2004 | B1 |
6813511 | Diab et al. | Nov 2004 | B2 |
6816241 | Grubisic | Nov 2004 | B2 |
6816741 | Diab | Nov 2004 | B2 |
6817979 | Nihtila et al. | Nov 2004 | B2 |
6822564 | Al-Ali | Nov 2004 | B2 |
6826419 | Diab et al. | Nov 2004 | B2 |
6830711 | Mills et al. | Dec 2004 | B2 |
6837848 | Bonner et al. | Jan 2005 | B2 |
6841535 | Divita et al. | Jan 2005 | B2 |
6850787 | Weber et al. | Feb 2005 | B2 |
6850788 | Al-Ali | Feb 2005 | B2 |
6852083 | Caro et al. | Feb 2005 | B2 |
6855112 | Kao et al. | Feb 2005 | B2 |
6860266 | Blike | Mar 2005 | B2 |
6861639 | Al-Ali | Mar 2005 | B2 |
6876931 | Lorenz et al. | Apr 2005 | B2 |
6897788 | Khair et al. | May 2005 | B2 |
6898452 | Al-Ali et al. | May 2005 | B2 |
6907237 | Dorenbosch et al. | Jun 2005 | B1 |
6915149 | Ben-haim | Jul 2005 | B2 |
6920345 | Al-Ali et al. | Jul 2005 | B2 |
6931268 | Kiani-Azarbayjany et al. | Aug 2005 | B1 |
6934570 | Kiani et al. | Aug 2005 | B2 |
6939305 | Flaherty et al. | Sep 2005 | B2 |
6943348 | Coffin, IV | Sep 2005 | B1 |
6950687 | Al-Ali | Sep 2005 | B2 |
6952340 | Son et al. | Oct 2005 | B2 |
6956649 | Acosta et al. | Oct 2005 | B2 |
6961598 | Diab | Nov 2005 | B2 |
6970792 | Diab | Nov 2005 | B1 |
6979812 | Al-Ali | Dec 2005 | B2 |
6980419 | Smith et al. | Dec 2005 | B2 |
6983179 | Ben-haim | Jan 2006 | B2 |
6985764 | Mason et al. | Jan 2006 | B2 |
6988989 | Weiner et al. | Jan 2006 | B2 |
6990087 | Rao et al. | Jan 2006 | B2 |
6990364 | Ruchti et al. | Jan 2006 | B2 |
6993371 | Kiani et al. | Jan 2006 | B2 |
6996427 | Ali et al. | Feb 2006 | B2 |
6997884 | Ulmsten | Feb 2006 | B2 |
6998247 | Monfre et al. | Feb 2006 | B2 |
6999904 | Weber et al. | Feb 2006 | B2 |
7003338 | Weber et al. | Feb 2006 | B2 |
7003339 | Diab et al. | Feb 2006 | B2 |
7015451 | Dalke et al. | Mar 2006 | B2 |
7024233 | Ali et al. | Apr 2006 | B2 |
7025729 | De Chazal et al. | Apr 2006 | B2 |
7027849 | Al-Ali | Apr 2006 | B2 |
7030749 | Al-Ali | Apr 2006 | B2 |
7033761 | Shafer | Apr 2006 | B2 |
7035686 | Hogan | Apr 2006 | B2 |
7039449 | Al-Ali | May 2006 | B2 |
7041060 | Flaherty et al. | May 2006 | B2 |
7044918 | Diab | May 2006 | B2 |
7044930 | Stromberg | May 2006 | B2 |
7048687 | Reuss et al. | May 2006 | B1 |
7059769 | Potega | Jun 2006 | B1 |
7061428 | Amir et al. | Jun 2006 | B1 |
7063666 | Weng et al. | Jun 2006 | B2 |
7067893 | Mills et al. | Jun 2006 | B2 |
7079035 | Bock et al. | Jul 2006 | B2 |
D526719 | Richie, Jr. et al. | Aug 2006 | S |
7096052 | Mason et al. | Aug 2006 | B2 |
7096054 | Abdul-Hafiz et al. | Aug 2006 | B2 |
D529616 | Deros et al. | Oct 2006 | S |
7132641 | Schulz et al. | Nov 2006 | B2 |
7133710 | Acosta et al. | Nov 2006 | B2 |
7142901 | Kiani et al. | Nov 2006 | B2 |
7149561 | Diab | Dec 2006 | B2 |
7186966 | Al-Ali | Mar 2007 | B2 |
7188621 | DeVries et al. | Mar 2007 | B2 |
7190261 | Al-Ali | Mar 2007 | B2 |
7208119 | Kurtock et al. | Apr 2007 | B1 |
7215984 | Diab | May 2007 | B2 |
7215986 | Diab | May 2007 | B2 |
7221971 | Diab | May 2007 | B2 |
7225006 | Al-Ali et al. | May 2007 | B2 |
7225007 | Al-Ali | May 2007 | B2 |
RE39672 | Shehada et al. | Jun 2007 | E |
7229415 | Schwartz | Jun 2007 | B2 |
7239905 | Kiani-Azarbayjany et al. | Jul 2007 | B2 |
7241287 | Shehada et al. | Jul 2007 | B2 |
7244251 | Shehada et al. | Jul 2007 | B2 |
7245373 | Soller et al. | Jul 2007 | B2 |
7245953 | Parker | Jul 2007 | B1 |
7252659 | Shehada et al. | Aug 2007 | B2 |
7254429 | Schurman et al. | Aug 2007 | B2 |
7254431 | Al-Ali | Aug 2007 | B2 |
7254433 | Diab et al. | Aug 2007 | B2 |
7254434 | Schulz et al. | Aug 2007 | B2 |
7256708 | Rosenfeld | Aug 2007 | B2 |
7261697 | Berstein | Aug 2007 | B2 |
7264616 | Shehada et al. | Sep 2007 | B2 |
7267671 | Shehada et al. | Sep 2007 | B2 |
7272425 | Al-Ali | Sep 2007 | B2 |
7273454 | Raymond et al. | Sep 2007 | B2 |
7274955 | Kiani et al. | Sep 2007 | B2 |
D554263 | Al-Ali | Oct 2007 | S |
7280858 | Al-Ali et al. | Oct 2007 | B2 |
7285090 | Stivoric et al. | Oct 2007 | B2 |
7289835 | Mansfield et al. | Oct 2007 | B2 |
7292883 | De Felice et al. | Nov 2007 | B2 |
7294105 | Islam | Nov 2007 | B1 |
7295866 | Al-Ali | Nov 2007 | B2 |
7307543 | Rosenfeld | Dec 2007 | B2 |
7312709 | Kingston | Dec 2007 | B2 |
7313423 | Griffin et al. | Dec 2007 | B2 |
7314446 | Byrd et al. | Jan 2008 | B2 |
7315825 | Rosenfeld | Jan 2008 | B2 |
7321862 | Rosenfeld | Jan 2008 | B2 |
7322971 | Shehada et al. | Jan 2008 | B2 |
7328053 | Diab et al. | Feb 2008 | B1 |
7332784 | Mills et al. | Feb 2008 | B2 |
7340287 | Mason et al. | Mar 2008 | B2 |
7341559 | Schulz et al. | Mar 2008 | B2 |
7343186 | Lamego et al. | Mar 2008 | B2 |
D566282 | Al-Ali et al. | Apr 2008 | S |
7355512 | Al-Ali | Apr 2008 | B1 |
7356178 | Ziel et al. | Apr 2008 | B2 |
7356365 | Schurman | Apr 2008 | B2 |
7371981 | Abdul-Hafiz | May 2008 | B2 |
7373193 | Al-Ali et al. | May 2008 | B2 |
7373194 | Weber et al. | May 2008 | B2 |
7374535 | Schoenberg | May 2008 | B2 |
7376453 | Diab et al. | May 2008 | B1 |
7377794 | Al-Ali et al. | May 2008 | B2 |
7377899 | Weber et al. | May 2008 | B2 |
7378975 | Smith et al. | May 2008 | B1 |
7382247 | Welch et al. | Jun 2008 | B2 |
7383070 | Diab et al. | Jun 2008 | B2 |
7390299 | Weiner et al. | Jun 2008 | B2 |
7395158 | Monfre et al. | Jul 2008 | B2 |
7395216 | Rosenfeld | Jul 2008 | B2 |
7411509 | Rosenfeld | Aug 2008 | B2 |
7413546 | Agutter et al. | Aug 2008 | B2 |
7415297 | Al-Ali et al. | Aug 2008 | B2 |
7419483 | Shehada | Sep 2008 | B2 |
7428432 | Ali et al. | Sep 2008 | B2 |
7433827 | Rosenfeld | Oct 2008 | B2 |
7438683 | Al-Ali et al. | Oct 2008 | B2 |
7439856 | Weiner et al. | Oct 2008 | B2 |
7440787 | Diab | Oct 2008 | B2 |
7454240 | Diab et al. | Nov 2008 | B2 |
7454359 | Rosenfeld | Nov 2008 | B2 |
7454360 | Rosenfeld | Nov 2008 | B2 |
7462151 | Childre et al. | Dec 2008 | B2 |
7467002 | Weber et al. | Dec 2008 | B2 |
7467094 | Rosenfeld | Dec 2008 | B2 |
7469157 | Diab et al. | Dec 2008 | B2 |
7471969 | Diab et al. | Dec 2008 | B2 |
7471971 | Diab et al. | Dec 2008 | B2 |
7475019 | Rosenfeld | Jan 2009 | B2 |
7483729 | Al-Ali et al. | Jan 2009 | B2 |
7483730 | Diab et al. | Jan 2009 | B2 |
7489250 | Bock et al. | Feb 2009 | B2 |
7489958 | Diab et al. | Feb 2009 | B2 |
7496391 | Diab et al. | Feb 2009 | B2 |
7496393 | Diab et al. | Feb 2009 | B2 |
D587657 | Al-Ali et al. | Mar 2009 | S |
7497828 | Wilk et al. | Mar 2009 | B1 |
7499741 | Diab et al. | Mar 2009 | B2 |
7499835 | Weber et al. | Mar 2009 | B2 |
7500950 | Al-Ali et al. | Mar 2009 | B2 |
7509154 | Diab et al. | Mar 2009 | B2 |
7509494 | Al-Ali | Mar 2009 | B2 |
7510849 | Schurman et al. | Mar 2009 | B2 |
7514725 | Wojtczuk et al. | Apr 2009 | B2 |
7515043 | Welch et al. | Apr 2009 | B2 |
7515044 | Welch et al. | Apr 2009 | B2 |
7519406 | Blank et al. | Apr 2009 | B2 |
7526328 | Diab et al. | Apr 2009 | B2 |
D592507 | Wachman et al. | May 2009 | S |
7530942 | Diab | May 2009 | B1 |
7530949 | Al Ali et al. | May 2009 | B2 |
7530955 | Diab et al. | May 2009 | B2 |
7532919 | Soyemi et al. | May 2009 | B2 |
7549961 | Hwang | Jun 2009 | B1 |
7551717 | Tome et al. | Jun 2009 | B2 |
7559520 | Quijano et al. | Jul 2009 | B2 |
7563110 | Al-Ali et al. | Jul 2009 | B2 |
7577475 | Consentino et al. | Aug 2009 | B2 |
7590950 | Collins et al. | Sep 2009 | B2 |
7593230 | Abul-Haj et al. | Sep 2009 | B2 |
7596398 | Al-Ali et al. | Sep 2009 | B2 |
7597665 | Wilk et al. | Oct 2009 | B2 |
7606608 | Blank et al. | Oct 2009 | B2 |
7612999 | Clark et al. | Nov 2009 | B2 |
7616303 | Yang et al. | Nov 2009 | B2 |
7618375 | Flaherty | Nov 2009 | B2 |
7620674 | Ruchti et al. | Nov 2009 | B2 |
D606659 | Kiani et al. | Dec 2009 | S |
7629039 | Eckerbom et al. | Dec 2009 | B2 |
7639145 | Lawson et al. | Dec 2009 | B2 |
7640140 | Ruchti et al. | Dec 2009 | B2 |
7647083 | Al-Ali et al. | Jan 2010 | B2 |
7650291 | Rosenfeld | Jan 2010 | B2 |
D609193 | Al-Ali et al. | Feb 2010 | S |
7654966 | Westinskow et al. | Feb 2010 | B2 |
7684845 | Juan | Mar 2010 | B2 |
7689437 | Teller et al. | Mar 2010 | B1 |
RE41236 | Seely | Apr 2010 | E |
D614305 | Al-Ali et al. | Apr 2010 | S |
7693697 | Westinskow et al. | Apr 2010 | B2 |
7697966 | Monfre et al. | Apr 2010 | B2 |
7698105 | Ruchti et al. | Apr 2010 | B2 |
RE41317 | Parker | May 2010 | E |
RE41333 | Blank et al. | May 2010 | E |
7722542 | Lia et al. | May 2010 | B2 |
7729733 | Al-Ali et al. | Jun 2010 | B2 |
7734320 | Al-Ali | Jun 2010 | B2 |
7736318 | Consentino et al. | Jun 2010 | B2 |
7740590 | Bernstein | Jun 2010 | B2 |
7761127 | Al-Ali et al. | Jul 2010 | B2 |
7761128 | Al-Ali et al. | Jul 2010 | B2 |
7763420 | Strizker et al. | Jul 2010 | B2 |
7764982 | Dalke et al. | Jul 2010 | B2 |
D621515 | Chua et al. | Aug 2010 | S |
D621516 | Kiani et al. | Aug 2010 | S |
7766818 | Iketani et al. | Aug 2010 | B2 |
7772799 | Wu | Aug 2010 | B2 |
7774060 | Westenskow et al. | Aug 2010 | B2 |
7778851 | Schoenberg et al. | Aug 2010 | B2 |
7791155 | Diab | Sep 2010 | B2 |
7794407 | Rothenberg | Sep 2010 | B2 |
7801581 | Diab | Sep 2010 | B2 |
7806830 | Bernstein | Oct 2010 | B2 |
7820184 | Strizker et al. | Oct 2010 | B2 |
7822452 | Schurman et al. | Oct 2010 | B2 |
RE41912 | Parker | Nov 2010 | E |
7831450 | Schoenberg | Nov 2010 | B2 |
7841986 | He et al. | Nov 2010 | B2 |
7844313 | Kiani et al. | Nov 2010 | B2 |
7844314 | Al-Ali | Nov 2010 | B2 |
7844315 | Al-Ali | Nov 2010 | B2 |
7848935 | Gotlib | Dec 2010 | B2 |
7858322 | Tymianski et al. | Dec 2010 | B2 |
7865222 | Weber et al. | Jan 2011 | B2 |
7865232 | Krishnaswamy et al. | Jan 2011 | B1 |
7873497 | Weber et al. | Jan 2011 | B2 |
7880606 | Al-Ali | Feb 2011 | B2 |
7880626 | Al-Ali et al. | Feb 2011 | B2 |
7881892 | Soyemi et al. | Feb 2011 | B2 |
7884314 | Hamada | Feb 2011 | B2 |
7890156 | Ooi et al. | Feb 2011 | B2 |
7891355 | Al-Ali et al. | Feb 2011 | B2 |
7894868 | Al-Ali et al. | Feb 2011 | B2 |
7899507 | Al-Ali et al. | Mar 2011 | B2 |
7899518 | Trepagnier et al. | Mar 2011 | B2 |
7904132 | Weber et al. | Mar 2011 | B2 |
7907945 | Deprun | Mar 2011 | B2 |
7909772 | Popov et al. | Mar 2011 | B2 |
7910875 | Al-Ali | Mar 2011 | B2 |
7914514 | Calderon | Mar 2011 | B2 |
7919713 | Al-Ali et al. | Apr 2011 | B2 |
7937128 | Al-Ali | May 2011 | B2 |
7937129 | Mason et al. | May 2011 | B2 |
7937130 | Diab et al. | May 2011 | B2 |
7941199 | Kiani | May 2011 | B2 |
7951086 | Flaherty et al. | May 2011 | B2 |
7957780 | Lamego et al. | Jun 2011 | B2 |
7962188 | Kiani et al. | Jun 2011 | B2 |
7962190 | Diab et al. | Jun 2011 | B1 |
7963927 | Kelleher et al. | Jun 2011 | B2 |
7967749 | Hutchinson et al. | Jun 2011 | B2 |
7976472 | Kiani | Jul 2011 | B2 |
7988637 | Diab | Aug 2011 | B2 |
7988639 | Starks | Aug 2011 | B2 |
7990382 | Kiani | Aug 2011 | B2 |
7991446 | Al-Ali et al. | Aug 2011 | B2 |
7991463 | Kelleher et al. | Aug 2011 | B2 |
7991625 | Rosenfeld | Aug 2011 | B2 |
8000761 | Al-Ali | Aug 2011 | B2 |
8008088 | Bellott et al. | Aug 2011 | B2 |
RE42753 | Kiani-Azarbayjany et al. | Sep 2011 | E |
8019400 | Diab et al. | Sep 2011 | B2 |
8027846 | Schoenberg | Sep 2011 | B2 |
8028701 | Al-Ali et al. | Oct 2011 | B2 |
8029765 | Bellott et al. | Oct 2011 | B2 |
8033996 | Behar | Oct 2011 | B2 |
8036727 | Schurman et al. | Oct 2011 | B2 |
8036728 | Diab et al. | Oct 2011 | B2 |
8036736 | Snyder et al. | Oct 2011 | B2 |
8038625 | Afonso et al. | Oct 2011 | B2 |
8046040 | Ali et al. | Oct 2011 | B2 |
8046041 | Diab et al. | Oct 2011 | B2 |
8046042 | Diab et al. | Oct 2011 | B2 |
8048040 | Kiani | Nov 2011 | B2 |
8050728 | Al-Ali et al. | Nov 2011 | B2 |
8068104 | Rampersad | Nov 2011 | B2 |
8073707 | Teller et al. | Dec 2011 | B2 |
8094013 | Lee et al. | Jan 2012 | B1 |
8107397 | Bagchi et al. | Jan 2012 | B1 |
RE43169 | Parker | Feb 2012 | E |
8118620 | Al-Ali et al. | Feb 2012 | B2 |
8126528 | Diab et al. | Feb 2012 | B2 |
8128572 | Diab et al. | Mar 2012 | B2 |
8130105 | Al-Ali et al. | Mar 2012 | B2 |
8145287 | Diab et al. | Mar 2012 | B2 |
8150487 | Diab et al. | Apr 2012 | B2 |
D659836 | Bensch et al. | May 2012 | S |
8170887 | Rosenfeld | May 2012 | B2 |
8175672 | Parker | May 2012 | B2 |
8175895 | Rosenfeld | May 2012 | B2 |
8180420 | Diab et al. | May 2012 | B2 |
8182429 | Mason | May 2012 | B2 |
8182443 | Kiani | May 2012 | B1 |
8185180 | Diab et al. | May 2012 | B2 |
8190223 | Al-Ali et al. | May 2012 | B2 |
8190227 | Diab et al. | May 2012 | B2 |
8200308 | Zhang et al. | Jun 2012 | B2 |
8203438 | Kiani et al. | Jun 2012 | B2 |
8203704 | Merritt et al. | Jun 2012 | B2 |
8204566 | Schurman et al. | Jun 2012 | B2 |
8206312 | Farquhar | Jun 2012 | B2 |
8214007 | Baker et al. | Jul 2012 | B2 |
8219172 | Schurman et al. | Jul 2012 | B2 |
8224411 | Al-Ali et al. | Jul 2012 | B2 |
8228181 | Al-Ali | Jul 2012 | B2 |
8229532 | Davis | Jul 2012 | B2 |
8229533 | Diab et al. | Jul 2012 | B2 |
8233955 | Al-Ali et al. | Jul 2012 | B2 |
8235907 | Wilk et al. | Aug 2012 | B2 |
8239780 | Manetta et al. | Aug 2012 | B2 |
8241213 | Lynn et al. | Aug 2012 | B2 |
8244325 | Al-Ali et al. | Aug 2012 | B2 |
8249815 | Taylor | Aug 2012 | B2 |
8255026 | Al-Ali | Aug 2012 | B1 |
8255027 | Al-Ali et al. | Aug 2012 | B2 |
8255028 | Al-Ali et al. | Aug 2012 | B2 |
8260577 | Weber et al. | Sep 2012 | B2 |
8265723 | McHale et al. | Sep 2012 | B1 |
8274360 | Sampath et al. | Sep 2012 | B2 |
8280473 | Al-Ali | Oct 2012 | B2 |
8294588 | Fisher et al. | Oct 2012 | B2 |
8294716 | Lord et al. | Oct 2012 | B2 |
8301217 | Al-Ali et al. | Oct 2012 | B2 |
8306596 | Schurman et al. | Nov 2012 | B2 |
8310336 | Muhsin et al. | Nov 2012 | B2 |
8311747 | Taylor | Nov 2012 | B2 |
8311748 | Taylor et al. | Nov 2012 | B2 |
8315683 | Al-Ali et al. | Nov 2012 | B2 |
8315812 | Taylor | Nov 2012 | B2 |
8315813 | Taylor et al. | Nov 2012 | B2 |
8315814 | Taylor et al. | Nov 2012 | B2 |
8321150 | Taylor | Nov 2012 | B2 |
RE43860 | Parker | Dec 2012 | E |
8326649 | Rosenfeld | Dec 2012 | B2 |
8328793 | Birkenbach et al. | Dec 2012 | B2 |
8337403 | Al-Ali et al. | Dec 2012 | B2 |
8346330 | Lamego | Jan 2013 | B2 |
8353842 | Al-Ali et al. | Jan 2013 | B2 |
8355766 | MacNeish, III et al. | Jan 2013 | B2 |
8359080 | Diab et al. | Jan 2013 | B2 |
8360936 | Dibenedetto et al. | Jan 2013 | B2 |
8364223 | Al-Ali et al. | Jan 2013 | B2 |
8364226 | Diab et al. | Jan 2013 | B2 |
8374665 | Lamego | Feb 2013 | B2 |
8385995 | Al-Ali et al. | Feb 2013 | B2 |
8385996 | Smith et al. | Feb 2013 | B2 |
D679018 | Fullerton et al. | Mar 2013 | S |
8388353 | Kiani et al. | Mar 2013 | B2 |
8399822 | Al-Ali | Mar 2013 | B2 |
8401602 | Kiani | Mar 2013 | B2 |
8401874 | Rosenfeld | Mar 2013 | B2 |
8405608 | Al-Ali et al. | Mar 2013 | B2 |
8414499 | Al-Ali et al. | Apr 2013 | B2 |
8418524 | Al-Ali | Apr 2013 | B2 |
8423106 | Lamego et al. | Apr 2013 | B2 |
8428967 | Olsen et al. | Apr 2013 | B2 |
8430817 | Al-Ali et al. | Apr 2013 | B1 |
8437825 | Dalvi et al. | May 2013 | B2 |
8455290 | Siskavich | Jun 2013 | B2 |
8457703 | Al-Ali | Jun 2013 | B2 |
8457707 | Kiani | Jun 2013 | B2 |
8463349 | Diab et al. | Jun 2013 | B2 |
8466286 | Bellot et al. | Jun 2013 | B2 |
8471713 | Poeze et al. | Jun 2013 | B2 |
8473020 | Kiani et al. | Jun 2013 | B2 |
8483787 | Al-Ali et al. | Jul 2013 | B2 |
8489167 | Buxton et al. | Jul 2013 | B2 |
8489364 | Weber et al. | Jul 2013 | B2 |
8498684 | Weber et al. | Jul 2013 | B2 |
8504128 | Blank et al. | Aug 2013 | B2 |
8506480 | Banet et al. | Aug 2013 | B2 |
8509867 | Workman et al. | Aug 2013 | B2 |
8514086 | Harper et al. | Aug 2013 | B2 |
8515509 | Bruinsma et al. | Aug 2013 | B2 |
8523781 | Al-Ali | Sep 2013 | B2 |
8529301 | Al-Ali et al. | Sep 2013 | B2 |
8532727 | Ali et al. | Sep 2013 | B2 |
8532728 | Diab et al. | Sep 2013 | B2 |
D692145 | Al-Ali et al. | Oct 2013 | S |
8547209 | Kiani et al. | Oct 2013 | B2 |
8548548 | Al-Ali | Oct 2013 | B2 |
8548549 | Schurman et al. | Oct 2013 | B2 |
8548550 | Al-Ali et al. | Oct 2013 | B2 |
8549600 | Shedrinsky | Oct 2013 | B2 |
8560032 | Al-Ali et al. | Oct 2013 | B2 |
8560034 | Diab et al. | Oct 2013 | B1 |
8565847 | Buxton et al. | Oct 2013 | B2 |
8570167 | Al-Ali | Oct 2013 | B2 |
8570503 | Vo et al. | Oct 2013 | B2 |
8571617 | Reichgott et al. | Oct 2013 | B2 |
8571618 | Lamego et al. | Oct 2013 | B1 |
8571619 | Al-Ali et al. | Oct 2013 | B2 |
8577431 | Lamego et al. | Nov 2013 | B2 |
8578082 | Medina et al. | Nov 2013 | B2 |
8579813 | Causey, III et al. | Nov 2013 | B2 |
8581732 | Al-Ali et al. | Nov 2013 | B2 |
8584345 | Al-Ali et al. | Nov 2013 | B2 |
8588880 | Abdul-Hafiz et al. | Nov 2013 | B2 |
8588924 | Dion | Nov 2013 | B2 |
8597287 | Benamou et al. | Dec 2013 | B2 |
8600467 | Al-Ali et al. | Dec 2013 | B2 |
8600777 | Schoenberg | Dec 2013 | B2 |
8606342 | Diab | Dec 2013 | B2 |
8620678 | Gotlib | Dec 2013 | B2 |
8626255 | Al-Ali et al. | Jan 2014 | B2 |
8630691 | Lamego et al. | Jan 2014 | B2 |
8634889 | Al-Ali et al. | Jan 2014 | B2 |
8641631 | Sierra et al. | Feb 2014 | B2 |
8652060 | Al-Ali | Feb 2014 | B2 |
8663107 | Kiani | Mar 2014 | B2 |
8666468 | Al-Ali | Mar 2014 | B1 |
8667967 | Al-Ali et al. | Mar 2014 | B2 |
8670811 | O'Reilly | Mar 2014 | B2 |
8670814 | Diab et al. | Mar 2014 | B2 |
8676286 | Weber et al. | Mar 2014 | B2 |
8682407 | Al-Ali | Mar 2014 | B2 |
RE44823 | Parker | Apr 2014 | E |
RE44875 | Kiani et al. | Apr 2014 | E |
8688183 | Bruinsma et al. | Apr 2014 | B2 |
8690771 | Wekell et al. | Apr 2014 | B2 |
8690799 | Telfort et al. | Apr 2014 | B2 |
8700112 | Kiani | Apr 2014 | B2 |
8702627 | Telfort et al. | Apr 2014 | B2 |
8706179 | Parker | Apr 2014 | B2 |
8712494 | MacNeish, III et al. | Apr 2014 | B1 |
8715206 | Telfort et al. | May 2014 | B2 |
8718735 | Lamego et al. | May 2014 | B2 |
8718737 | Diab et al. | May 2014 | B2 |
8718738 | Blank et al. | May 2014 | B2 |
8720249 | Al-Ali | May 2014 | B2 |
8721541 | Al-Ali et al. | May 2014 | B2 |
8721542 | Al-Ali et al. | May 2014 | B2 |
8723677 | Kiani | May 2014 | B1 |
8740792 | Kiani et al. | Jun 2014 | B1 |
8753274 | Ziv et al. | Jun 2014 | B2 |
8754776 | Poeze et al. | Jun 2014 | B2 |
8755535 | Telfort et al. | Jun 2014 | B2 |
8755856 | Diab et al. | Jun 2014 | B2 |
8755872 | Marinow | Jun 2014 | B1 |
8758020 | Burdea et al. | Jun 2014 | B2 |
8761850 | Lamego | Jun 2014 | B2 |
D709846 | Oswaks | Jul 2014 | S |
8764671 | Kiani | Jul 2014 | B2 |
8768423 | Shakespeare et al. | Jul 2014 | B2 |
8771204 | Telfort et al. | Jul 2014 | B2 |
8777634 | Kiani et al. | Jul 2014 | B2 |
8781543 | Diab et al. | Jul 2014 | B2 |
8781544 | Al-Ali et al. | Jul 2014 | B2 |
8781549 | Al-Ali et al. | Jul 2014 | B2 |
8788003 | Schurman et al. | Jul 2014 | B2 |
8790268 | Al-Ali | Jul 2014 | B2 |
8792950 | Larsen et al. | Jul 2014 | B2 |
8801613 | Al-Ali et al. | Aug 2014 | B2 |
8818477 | Soller | Aug 2014 | B2 |
8821397 | Al-Ali et al. | Sep 2014 | B2 |
8821415 | Al-Ali et al. | Sep 2014 | B2 |
8830449 | Lamego et al. | Sep 2014 | B1 |
8831700 | Schurman et al. | Sep 2014 | B2 |
8840549 | Al-Ali et al. | Sep 2014 | B2 |
8847740 | Kiani et al. | Sep 2014 | B2 |
8849365 | Smith et al. | Sep 2014 | B2 |
8852094 | Al-Ali et al. | Oct 2014 | B2 |
8852994 | Wojtczuk et al. | Oct 2014 | B2 |
8866620 | Amir | Oct 2014 | B2 |
8868147 | Stippick et al. | Oct 2014 | B2 |
8868150 | Al-Ali et al. | Oct 2014 | B2 |
8870792 | Al-Ali et al. | Oct 2014 | B2 |
8873035 | Yang et al. | Oct 2014 | B2 |
8878888 | Rosenfeld | Nov 2014 | B2 |
8882666 | Goldberg et al. | Nov 2014 | B1 |
8886271 | Kiani et al. | Nov 2014 | B2 |
8888539 | Al-Ali et al. | Nov 2014 | B2 |
8888708 | Diab et al. | Nov 2014 | B2 |
8892180 | Weber et al. | Nov 2014 | B2 |
8897847 | Al-Ali | Nov 2014 | B2 |
8907287 | Vanderpohl | Dec 2014 | B2 |
8909310 | Lamego et al. | Dec 2014 | B2 |
8909330 | McCombie et al. | Dec 2014 | B2 |
8911377 | Al-Ali | Dec 2014 | B2 |
8912909 | Al-Ali et al. | Dec 2014 | B2 |
8920317 | Al-Ali et al. | Dec 2014 | B2 |
8921699 | Al-Ali et al. | Dec 2014 | B2 |
8922382 | Al-Ali et al. | Dec 2014 | B2 |
8929964 | Al-Ali et al. | Jan 2015 | B2 |
8942777 | Diab et al. | Jan 2015 | B2 |
8948834 | Diab et al. | Feb 2015 | B2 |
8948835 | Diab | Feb 2015 | B2 |
8951248 | Messerly et al. | Feb 2015 | B2 |
8956292 | Wekell et al. | Feb 2015 | B2 |
8965471 | Lamego | Feb 2015 | B2 |
8983564 | Al-Ali | Mar 2015 | B2 |
8989831 | Al-Ali et al. | Mar 2015 | B2 |
8996085 | Kiani et al. | Mar 2015 | B2 |
8998809 | Kiani | Apr 2015 | B2 |
9028429 | Telfort et al. | May 2015 | B2 |
9037207 | Al-Ali et al. | May 2015 | B2 |
9057689 | Soller | Jun 2015 | B2 |
9060721 | Reichgott et al. | Jun 2015 | B2 |
9066666 | Kiani | Jun 2015 | B2 |
9066680 | Al-Ali et al. | Jun 2015 | B1 |
9072474 | Al-Ali et al. | Jul 2015 | B2 |
9078560 | Schurman et al. | Jul 2015 | B2 |
9084569 | Weber et al. | Jul 2015 | B2 |
9095291 | Soller | Aug 2015 | B2 |
9095316 | Welch et al. | Aug 2015 | B2 |
9104789 | Gross et al. | Aug 2015 | B2 |
9106038 | Telfort et al. | Aug 2015 | B2 |
9107625 | Telfort et al. | Aug 2015 | B2 |
9107626 | Al-Ali et al. | Aug 2015 | B2 |
9113831 | Al-Ali | Aug 2015 | B2 |
9113832 | Al-Ali | Aug 2015 | B2 |
9119595 | Lamego | Sep 2015 | B2 |
9125578 | Grunwald | Sep 2015 | B2 |
9131881 | Diab et al. | Sep 2015 | B2 |
9131882 | Al-Ali et al. | Sep 2015 | B2 |
9131883 | Al-Ali | Sep 2015 | B2 |
9131917 | Telfort et al. | Sep 2015 | B2 |
9138180 | Coverston et al. | Sep 2015 | B1 |
9138182 | Al-Ali et al. | Sep 2015 | B2 |
9138192 | Weber et al. | Sep 2015 | B2 |
9142117 | Muhsin et al. | Sep 2015 | B2 |
9153112 | Kiani et al. | Oct 2015 | B1 |
9153121 | Kiani et al. | Oct 2015 | B2 |
9161696 | Al-Ali et al. | Oct 2015 | B2 |
9161713 | Al-Ali et al. | Oct 2015 | B2 |
9167995 | Lamego et al. | Oct 2015 | B2 |
9176141 | Al-Ali et al. | Nov 2015 | B2 |
9186102 | Bruinsma et al. | Nov 2015 | B2 |
9192312 | Al-Ali | Nov 2015 | B2 |
9192329 | Al-Ali | Nov 2015 | B2 |
9192351 | Telfort et al. | Nov 2015 | B1 |
9195385 | Al-Ali et al. | Nov 2015 | B2 |
D745167 | Canas et al. | Dec 2015 | S |
9211072 | Kiani | Dec 2015 | B2 |
9211095 | Al-Ali | Dec 2015 | B1 |
9218454 | Kiani et al. | Dec 2015 | B2 |
9226696 | Kiani | Jan 2016 | B2 |
9241662 | Al-Ali et al. | Jan 2016 | B2 |
9245668 | Vo et al. | Jan 2016 | B1 |
9259185 | Abdul-Hafiz et al. | Feb 2016 | B2 |
9262586 | Steiger et al. | Feb 2016 | B2 |
9267572 | Barker et al. | Feb 2016 | B2 |
9277880 | Poeze et al. | Mar 2016 | B2 |
9289167 | Diab et al. | Mar 2016 | B2 |
9295421 | Kiani et al. | Mar 2016 | B2 |
9307928 | Al-Ali et al. | Apr 2016 | B1 |
9323894 | Kiani | Apr 2016 | B2 |
D755392 | Hwang et al. | May 2016 | S |
9326712 | Kiani | May 2016 | B1 |
9333316 | Kiani | May 2016 | B2 |
9339220 | Lamego et al. | May 2016 | B2 |
9341565 | Lamego et al. | May 2016 | B2 |
9351673 | Diab et al. | May 2016 | B2 |
9351675 | Al-Ali et al. | May 2016 | B2 |
9364181 | Kiani et al. | Jun 2016 | B2 |
9368671 | Wojtczuk et al. | Jun 2016 | B2 |
9370325 | Al-Ali et al. | Jun 2016 | B2 |
9370326 | McHale et al. | Jun 2016 | B2 |
9370335 | Al-Ali et al. | Jun 2016 | B2 |
9375185 | Ali et al. | Jun 2016 | B2 |
9386953 | Al-Ali | Jul 2016 | B2 |
9386961 | Al-Ali et al. | Jul 2016 | B2 |
9392945 | Al-Ali et al. | Jul 2016 | B2 |
9397448 | Al-Ali et al. | Jul 2016 | B2 |
9408542 | Kinast et al. | Aug 2016 | B1 |
9414784 | Berme et al. | Aug 2016 | B1 |
9436645 | Al-Ali et al. | Sep 2016 | B2 |
9445759 | Lamego et al. | Sep 2016 | B1 |
9466919 | Kiani et al. | Oct 2016 | B2 |
9474474 | Lamego et al. | Oct 2016 | B2 |
9480422 | Al-Ali | Nov 2016 | B2 |
9480435 | Olsen | Nov 2016 | B2 |
9492110 | Al-Ali et al. | Nov 2016 | B2 |
9510779 | Poeze et al. | Dec 2016 | B2 |
9517024 | Kiani et al. | Dec 2016 | B2 |
9529762 | Gisler et al. | Dec 2016 | B2 |
9532722 | Lamego et al. | Jan 2017 | B2 |
9538949 | Al-Ali et al. | Jan 2017 | B2 |
9538980 | Telfort et al. | Jan 2017 | B2 |
9549696 | Lamego et al. | Jan 2017 | B2 |
9554737 | Schurman et al. | Jan 2017 | B2 |
9560996 | Kiani | Feb 2017 | B2 |
9560998 | Al-Ali et al. | Feb 2017 | B2 |
9566019 | Al-Ali et al. | Feb 2017 | B2 |
9579039 | Jansen et al. | Feb 2017 | B2 |
9591975 | Dalvi et al. | Mar 2017 | B2 |
9622692 | Lamego et al. | Apr 2017 | B2 |
9622693 | Diab | Apr 2017 | B2 |
D788312 | Al-Ali et al. | May 2017 | S |
9636055 | Al-Ali et al. | May 2017 | B2 |
9636056 | Al-Ali | May 2017 | B2 |
9649054 | Lamego et al. | May 2017 | B2 |
9662052 | Al-Ali et al. | May 2017 | B2 |
9668679 | Schurman et al. | Jun 2017 | B2 |
9668680 | Bruinsma et al. | Jun 2017 | B2 |
9668703 | Al-Ali | Jun 2017 | B2 |
9675286 | Diab | Jun 2017 | B2 |
9687160 | Kiani | Jun 2017 | B2 |
9693719 | Al-Ali et al. | Jul 2017 | B2 |
9693737 | Al-Ali | Jul 2017 | B2 |
9697928 | Al-Ali et al. | Jul 2017 | B2 |
9717425 | Kiani et al. | Aug 2017 | B2 |
9717458 | Lamego et al. | Aug 2017 | B2 |
9724016 | Al-Ali et al. | Aug 2017 | B1 |
9724024 | Al-Ali | Aug 2017 | B2 |
9724025 | Kiani et al. | Aug 2017 | B1 |
9730640 | Diab et al. | Aug 2017 | B2 |
9743887 | Al-Ali et al. | Aug 2017 | B2 |
9749232 | Sampath et al. | Aug 2017 | B2 |
9750442 | Olsen | Sep 2017 | B2 |
9750443 | Smith et al. | Sep 2017 | B2 |
9750461 | Telfort | Sep 2017 | B1 |
9775545 | Al-Ali et al. | Oct 2017 | B2 |
9775546 | Diab et al. | Oct 2017 | B2 |
9775570 | Al-Ali | Oct 2017 | B2 |
9778079 | Al-Ali et al. | Oct 2017 | B1 |
9782077 | Lamego et al. | Oct 2017 | B2 |
9782110 | Kiani | Oct 2017 | B2 |
9787568 | Lamego et al. | Oct 2017 | B2 |
9788735 | Al-Ali | Oct 2017 | B2 |
9788768 | Al-Ali et al. | Oct 2017 | B2 |
9795300 | Al-Ali | Oct 2017 | B2 |
9795310 | Al-Ali | Oct 2017 | B2 |
9795358 | Telfort et al. | Oct 2017 | B2 |
9795739 | Al-Ali et al. | Oct 2017 | B2 |
9801556 | Kiani | Oct 2017 | B2 |
9801588 | Weber et al. | Oct 2017 | B2 |
9808188 | Perea et al. | Nov 2017 | B1 |
9814418 | Weber et al. | Nov 2017 | B2 |
9820691 | Kiani | Nov 2017 | B2 |
9833152 | Kiani et al. | Dec 2017 | B2 |
9833180 | Shakespeare et al. | Dec 2017 | B2 |
9839379 | Al-Ali et al. | Dec 2017 | B2 |
9839381 | Weber et al. | Dec 2017 | B1 |
9847002 | Kiani et al. | Dec 2017 | B2 |
9847749 | Kiani et al. | Dec 2017 | B2 |
9848800 | Lee et al. | Dec 2017 | B1 |
9848806 | Al-Ali et al. | Dec 2017 | B2 |
9848807 | Lamego | Dec 2017 | B2 |
9861298 | Eckerbom et al. | Jan 2018 | B2 |
9861304 | Al-Ali et al. | Jan 2018 | B2 |
9861305 | Weber et al. | Jan 2018 | B1 |
9867578 | Al-Ali et al. | Jan 2018 | B2 |
9872623 | Al-Ali | Jan 2018 | B2 |
9876320 | Coverston et al. | Jan 2018 | B2 |
9877650 | Muhsin et al. | Jan 2018 | B2 |
9877686 | Al-Ali et al. | Jan 2018 | B2 |
9891079 | Dalvi | Feb 2018 | B2 |
9895107 | Al-Ali et al. | Feb 2018 | B2 |
9913617 | Al-Ali et al. | Mar 2018 | B2 |
9924893 | Schurman et al. | Mar 2018 | B2 |
9924897 | Abdul-Hafiz | Mar 2018 | B1 |
9936917 | Poeze et al. | Apr 2018 | B2 |
9943269 | Muhsin et al. | Apr 2018 | B2 |
9949676 | Al-Ali | Apr 2018 | B2 |
9955937 | Telfort | May 2018 | B2 |
9965946 | Al-Ali et al. | May 2018 | B2 |
9980667 | Kiani et al. | May 2018 | B2 |
D820865 | Muhsin et al. | Jun 2018 | S |
9986919 | Lamego et al. | Jun 2018 | B2 |
9986952 | Dalvi et al. | Jun 2018 | B2 |
9989560 | Poeze et al. | Jun 2018 | B2 |
9993207 | Al-Ali et al. | Jun 2018 | B2 |
10007758 | Al-Ali et al. | Jun 2018 | B2 |
D822215 | Al-Ali et al. | Jul 2018 | S |
D822216 | Barker et al. | Jul 2018 | S |
10010031 | Liu et al. | Jul 2018 | B1 |
10010276 | Al-Ali et al. | Jul 2018 | B2 |
10032002 | Kiani et al. | Jul 2018 | B2 |
10039482 | Al-Ali et al. | Aug 2018 | B2 |
10052037 | Kinast et al. | Aug 2018 | B2 |
10058275 | Al-Ali et al. | Aug 2018 | B2 |
10064562 | Al-Ali | Sep 2018 | B2 |
10086138 | Novak, Jr. | Oct 2018 | B1 |
10092200 | Al-Ali et al. | Oct 2018 | B2 |
10092249 | Kiani et al. | Oct 2018 | B2 |
10098550 | Al-Ali et al. | Oct 2018 | B2 |
10098591 | Al-Ali et al. | Oct 2018 | B2 |
10098610 | Al-Ali et al. | Oct 2018 | B2 |
10111591 | Dyell et al. | Oct 2018 | B2 |
D833624 | DeJong et al. | Nov 2018 | S |
10123726 | Al-Ali et al. | Nov 2018 | B2 |
10123729 | Dyell et al. | Nov 2018 | B2 |
10130289 | Al-Ali et al. | Nov 2018 | B2 |
10130291 | Schurman et al. | Nov 2018 | B2 |
D835282 | Barker et al. | Dec 2018 | S |
D835283 | Barker et al. | Dec 2018 | S |
D835284 | Barker et al. | Dec 2018 | S |
D835285 | Barker et al. | Dec 2018 | S |
10149616 | Al-Ali et al. | Dec 2018 | B2 |
10154815 | Al-Ali et al. | Dec 2018 | B2 |
10159412 | Lamego et al. | Dec 2018 | B2 |
10188296 | Al-Ali et al. | Jan 2019 | B2 |
10188331 | Al-Ali et al. | Jan 2019 | B1 |
10188348 | Kiani et al. | Jan 2019 | B2 |
RE47218 | Ali-Ali | Feb 2019 | E |
RE47244 | Kiani et al. | Feb 2019 | E |
RE47249 | Kiani et al. | Feb 2019 | E |
10194847 | Al-Ali | Feb 2019 | B2 |
10194848 | Kiani et al. | Feb 2019 | B1 |
10201298 | Al-Ali et al. | Feb 2019 | B2 |
10205272 | Kiani et al. | Feb 2019 | B2 |
10205291 | Scruggs et al. | Feb 2019 | B2 |
10213108 | Al-Ali | Feb 2019 | B2 |
10219706 | Al-Ali | Mar 2019 | B2 |
10219746 | McHale et al. | Mar 2019 | B2 |
10226187 | Al-Ali et al. | Mar 2019 | B2 |
10226576 | Kiani | Mar 2019 | B2 |
10231657 | Al-Ali et al. | Mar 2019 | B2 |
10231670 | Blank et al. | Mar 2019 | B2 |
10231676 | Al-Ali et al. | Mar 2019 | B2 |
RE47353 | Kiani et al. | Apr 2019 | E |
10251585 | Al-Ali et al. | Apr 2019 | B2 |
10251586 | Lamego | Apr 2019 | B2 |
10255994 | Sampath et al. | Apr 2019 | B2 |
10258265 | Poeze et al. | Apr 2019 | B1 |
10258266 | Poeze et al. | Apr 2019 | B1 |
10271748 | Al-Ali | Apr 2019 | B2 |
10278626 | Schurman et al. | May 2019 | B2 |
10278648 | Al-Ali et al. | May 2019 | B2 |
10279247 | Kiani | May 2019 | B2 |
10292628 | Poeze et al. | May 2019 | B1 |
10292657 | Abdul-Hafiz et al. | May 2019 | B2 |
10292664 | Al-Ali | May 2019 | B2 |
10299708 | Poeze et al. | May 2019 | B1 |
10299709 | Perea et al. | May 2019 | B2 |
10299720 | Brown et al. | May 2019 | B2 |
10305775 | Lamego et al. | May 2019 | B2 |
10307111 | Muhsin et al. | Jun 2019 | B2 |
10325681 | Sampath et al. | Jun 2019 | B2 |
10327337 | Triman et al. | Jun 2019 | B2 |
10327713 | Barker et al. | Jun 2019 | B2 |
10332630 | Al-Ali | Jun 2019 | B2 |
10335033 | Al-Ali | Jul 2019 | B2 |
10335068 | Poeze et al. | Jul 2019 | B2 |
10335072 | Al-Ali et al. | Jul 2019 | B2 |
10342470 | Al-Ali et al. | Jul 2019 | B2 |
10342487 | Al-Ali et al. | Jul 2019 | B2 |
10342497 | Al-Ali et al. | Jul 2019 | B2 |
10349895 | Telfort et al. | Jul 2019 | B2 |
10349898 | Al-Ali et al. | Jul 2019 | B2 |
10354504 | Kiani et al. | Jul 2019 | B2 |
10357206 | Weber et al. | Jul 2019 | B2 |
10357209 | Al-Ali | Jul 2019 | B2 |
10366787 | Sampath et al. | Jul 2019 | B2 |
10368787 | Reichgott et al. | Aug 2019 | B2 |
10376190 | Poeze et al. | Aug 2019 | B1 |
10376191 | Poeze et al. | Aug 2019 | B1 |
10383520 | Wojtczuk et al. | Aug 2019 | B2 |
10383527 | Al-Ali | Aug 2019 | B2 |
10388120 | Muhsin et al. | Aug 2019 | B2 |
10398320 | Kiani et al. | Sep 2019 | B2 |
10405804 | Al-Ali et al. | Sep 2019 | B2 |
10413666 | Al-Ali et al. | Sep 2019 | B2 |
10420493 | Al-Ali et al. | Sep 2019 | B2 |
D864120 | Forrest et al. | Oct 2019 | S |
10433776 | Al-Ali | Oct 2019 | B2 |
10441181 | Telfort et al. | Oct 2019 | B1 |
10441196 | Eckerbom et al. | Oct 2019 | B2 |
10448844 | Al-Ali et al. | Oct 2019 | B2 |
10448871 | Al-Ali | Oct 2019 | B2 |
10456038 | Lamego et al. | Oct 2019 | B2 |
10463340 | Telfort et al. | Nov 2019 | B2 |
10471159 | Lapotko et al. | Nov 2019 | B1 |
10505311 | Al-Ali et al. | Dec 2019 | B2 |
10512436 | Muhsin et al. | Dec 2019 | B2 |
10524738 | Olsen | Jan 2020 | B2 |
10532174 | Al-Ali | Jan 2020 | B2 |
10537285 | Sherim et al. | Jan 2020 | B2 |
10542903 | Al-Ali et al. | Jan 2020 | B2 |
10555678 | Dalvi et al. | Feb 2020 | B2 |
10568553 | O'Neil et al. | Feb 2020 | B2 |
RE47882 | Al-Ali | Mar 2020 | E |
10608817 | Haider et al. | Mar 2020 | B2 |
D880477 | Forrest et al. | Apr 2020 | S |
10617302 | Al-Ali et al. | Apr 2020 | B2 |
10617335 | Al-Ali et al. | Apr 2020 | B2 |
10637181 | Al-Ali et al. | Apr 2020 | B2 |
D887548 | Abdul-Hafiz et al. | Jun 2020 | S |
D887549 | Abdul-Hafiz et al. | Jun 2020 | S |
10667764 | Ahmed et al. | Jun 2020 | B2 |
D890708 | Forrest et al. | Jul 2020 | S |
10721785 | Al-Ali | Jul 2020 | B2 |
10736518 | Al-Ali et al. | Aug 2020 | B2 |
10750984 | Pauley et al. | Aug 2020 | B2 |
D897098 | Al-Ali | Sep 2020 | S |
10779098 | Iswanto et al. | Sep 2020 | B2 |
10827961 | Iyengar et al. | Nov 2020 | B1 |
10828007 | Telfort et al. | Nov 2020 | B1 |
10832818 | Muhsin et al. | Nov 2020 | B2 |
10849554 | Shreim et al. | Dec 2020 | B2 |
10856750 | Indorf et al. | Dec 2020 | B2 |
10869602 | Al-Ali | Dec 2020 | B2 |
D906970 | Forrest et al. | Jan 2021 | S |
10912524 | Al-Ali et al. | Feb 2021 | B2 |
10918281 | Al-Ali et al. | Feb 2021 | B2 |
10925550 | Al-Ali et al. | Feb 2021 | B2 |
10932705 | Muhsin et al. | Mar 2021 | B2 |
10932729 | Kiani et al. | Mar 2021 | B2 |
10939878 | Kiani et al. | Mar 2021 | B2 |
10943450 | Kiani et al. | Mar 2021 | B2 |
D916135 | Indorf et al. | Apr 2021 | S |
D917550 | Indorf et al. | Apr 2021 | S |
D917564 | Indorf et al. | Apr 2021 | S |
D917704 | Al-Ali et al. | Apr 2021 | S |
10987066 | Chandran et al. | Apr 2021 | B2 |
10991135 | Al-Ali et al. | Apr 2021 | B2 |
D919094 | Al-Ali et al. | May 2021 | S |
D919100 | Al-Ali et al. | May 2021 | S |
11006867 | Al-Ali | May 2021 | B2 |
D921202 | Al-Ali et al. | Jun 2021 | S |
11024064 | Muhsin et al. | Jun 2021 | B2 |
11026604 | Chen et al. | Jun 2021 | B2 |
D925597 | Chandran et al. | Jul 2021 | S |
D927699 | Al-Ali et al. | Aug 2021 | S |
11076777 | Lee et al. | Aug 2021 | B2 |
11083397 | Al-Ali et al. | Aug 2021 | B2 |
11114188 | Poeze et al. | Sep 2021 | B2 |
20010011355 | Kawai | Aug 2001 | A1 |
20010028674 | Edlis et al. | Oct 2001 | A1 |
20010031922 | Weng et al. | Oct 2001 | A1 |
20010034477 | Mansfield et al. | Oct 2001 | A1 |
20010039199 | Shinzaki | Nov 2001 | A1 |
20010039483 | Brand et al. | Nov 2001 | A1 |
20010046366 | Susskind | Nov 2001 | A1 |
20010046862 | Coppinger et al. | Nov 2001 | A1 |
20010055978 | Herrod et al. | Dec 2001 | A1 |
20020010401 | Bushmakin et al. | Jan 2002 | A1 |
20020032386 | Sackner et al. | Mar 2002 | A1 |
20020038392 | De La Huerga | Mar 2002 | A1 |
20020045836 | Alkawwas | Apr 2002 | A1 |
20020052311 | Solomon et al. | May 2002 | A1 |
20020058864 | Mansfield et al. | May 2002 | A1 |
20020063690 | Chung et al. | May 2002 | A1 |
20020133080 | Apruzzese et al. | Sep 2002 | A1 |
20020140675 | Ali et al. | Oct 2002 | A1 |
20020165462 | Westbrook et al. | Nov 2002 | A1 |
20020177758 | Schoenberg | Nov 2002 | A1 |
20020198445 | Dominguez et al. | Dec 2002 | A1 |
20030013975 | Kiani | Jan 2003 | A1 |
20030018243 | Gerhardt et al. | Jan 2003 | A1 |
20030027326 | Ulmsten et al. | Feb 2003 | A1 |
20030052787 | Zerhusen et al. | Mar 2003 | A1 |
20030058838 | Wengrovitz | Mar 2003 | A1 |
20030083113 | Chua et al. | May 2003 | A1 |
20030144582 | Cohen et al. | Jul 2003 | A1 |
20030154108 | Fletcher-Haynes et al. | Aug 2003 | A1 |
20030156288 | Barnum et al. | Aug 2003 | A1 |
20030158466 | Lynn et al. | Aug 2003 | A1 |
20030212312 | Coffin, IV et al. | Nov 2003 | A1 |
20030216670 | Beggs | Nov 2003 | A1 |
20040009787 | Oh et al. | Jan 2004 | A1 |
20040013647 | Solomon et al. | Jan 2004 | A1 |
20040029619 | Liang et al. | Feb 2004 | A1 |
20040106163 | Workman, Jr. et al. | Jun 2004 | A1 |
20040122787 | Avinash et al. | Jun 2004 | A1 |
20040126007 | Ziel et al. | Jul 2004 | A1 |
20040139571 | Chang et al. | Jul 2004 | A1 |
20040147818 | Levy et al. | Jul 2004 | A1 |
20040186357 | Soderberg et al. | Sep 2004 | A1 |
20040230118 | Shehada et al. | Nov 2004 | A1 |
20040230132 | Shehada et al. | Nov 2004 | A1 |
20040230179 | Shehada et al. | Nov 2004 | A1 |
20040243017 | Causevic | Dec 2004 | A1 |
20040249291 | Honda et al. | Dec 2004 | A1 |
20040249670 | Noguchi et al. | Dec 2004 | A1 |
20040254431 | Shehada et al. | Dec 2004 | A1 |
20040254432 | Shehada et al. | Dec 2004 | A1 |
20040267103 | Li et al. | Dec 2004 | A1 |
20050020918 | Wilk et al. | Jan 2005 | A1 |
20050038332 | Saidara et al. | Feb 2005 | A1 |
20050038680 | McMahon | Feb 2005 | A1 |
20050055276 | Kiani et al. | Mar 2005 | A1 |
20050080336 | Byrd et al. | Apr 2005 | A1 |
20050096542 | Weng et al. | May 2005 | A1 |
20050113653 | Fox et al. | May 2005 | A1 |
20050124864 | Mack et al. | Jun 2005 | A1 |
20050125256 | Schoenberg | Jun 2005 | A1 |
20050164933 | Tymianski et al. | Jul 2005 | A1 |
20050171444 | Ono et al. | Aug 2005 | A1 |
20050188083 | Biondi et al. | Aug 2005 | A1 |
20050191294 | Arap et al. | Sep 2005 | A1 |
20050228297 | Banet et al. | Oct 2005 | A1 |
20050234317 | Kiani | Oct 2005 | A1 |
20050261598 | Banet et al. | Nov 2005 | A1 |
20050268401 | Dixon et al. | Dec 2005 | A1 |
20050277872 | Colby, Jr. et al. | Dec 2005 | A1 |
20060047214 | Fraden | Mar 2006 | A1 |
20060047215 | Barnes et al. | Mar 2006 | A1 |
20060049936 | Collins, Jr. et al. | Mar 2006 | A1 |
20060052718 | Parnagian | Mar 2006 | A1 |
20060058647 | Strommer et al. | Mar 2006 | A1 |
20060073719 | Kiani | Apr 2006 | A1 |
20060087606 | Munyon | Apr 2006 | A1 |
20060089543 | Kim et al. | Apr 2006 | A1 |
20060094936 | Russ | May 2006 | A1 |
20060122517 | Banet et al. | Jun 2006 | A1 |
20060149393 | Calderon | Jul 2006 | A1 |
20060154642 | Scannell, Jr. | Jul 2006 | A1 |
20060155175 | Ogino et al. | Jul 2006 | A1 |
20060161054 | Reuss et al. | Jul 2006 | A1 |
20060189871 | Al-Ali et al. | Aug 2006 | A1 |
20060217684 | Shehada et al. | Sep 2006 | A1 |
20060217685 | Shehada et al. | Sep 2006 | A1 |
20060224413 | Kim et al. | Oct 2006 | A1 |
20060235300 | Weng et al. | Oct 2006 | A1 |
20060252418 | Quinn et al. | Nov 2006 | A1 |
20060253042 | Stahmann et al. | Nov 2006 | A1 |
20070000490 | DeVries et al. | Jan 2007 | A1 |
20070002533 | Kogan et al. | Jan 2007 | A1 |
20070021675 | Childre et al. | Jan 2007 | A1 |
20070027368 | Collins et al. | Feb 2007 | A1 |
20070030116 | Feher | Feb 2007 | A1 |
20070032733 | Burton et al. | Feb 2007 | A1 |
20070055116 | Clark et al. | Mar 2007 | A1 |
20070055544 | Jung et al. | Mar 2007 | A1 |
20070060798 | Krupnik et al. | Mar 2007 | A1 |
20070073116 | Kiani et al. | Mar 2007 | A1 |
20070079012 | Walker | Apr 2007 | A1 |
20070088406 | Bennett et al. | Apr 2007 | A1 |
20070096897 | Weiner | May 2007 | A1 |
20070100222 | Mastrototaro et al. | May 2007 | A1 |
20070118399 | Avinash et al. | May 2007 | A1 |
20070118853 | Kreitzer et al. | May 2007 | A1 |
20070140475 | Kurtock et al. | Jun 2007 | A1 |
20070156033 | Causey et al. | Jul 2007 | A1 |
20070157285 | Frank et al. | Jul 2007 | A1 |
20070159332 | Koblasz | Jul 2007 | A1 |
20070163589 | DeVries et al. | Jul 2007 | A1 |
20070180140 | Welch et al. | Aug 2007 | A1 |
20070185390 | Perkins et al. | Aug 2007 | A1 |
20070197881 | Wolf et al. | Aug 2007 | A1 |
20070232941 | Rabinovich | Oct 2007 | A1 |
20070244377 | Cozad et al. | Oct 2007 | A1 |
20070244724 | Pendergast et al. | Oct 2007 | A1 |
20070254593 | Jollota et al. | Nov 2007 | A1 |
20070255114 | Ackermann et al. | Nov 2007 | A1 |
20070255116 | Mehta et al. | Nov 2007 | A1 |
20070255250 | Moberg et al. | Nov 2007 | A1 |
20070282212 | Sierra et al. | Dec 2007 | A1 |
20070282478 | Al-Ali et al. | Dec 2007 | A1 |
20070293906 | Cowan et al. | Dec 2007 | A1 |
20080000479 | Elaz et al. | Jan 2008 | A1 |
20080003200 | Arap et al. | Jan 2008 | A1 |
20080020799 | Itamiya et al. | Jan 2008 | A1 |
20080021854 | Jung et al. | Jan 2008 | A1 |
20080033661 | Syroid et al. | Feb 2008 | A1 |
20080039701 | Ali et al. | Feb 2008 | A1 |
20080053438 | DeVries et al. | Mar 2008 | A1 |
20080058657 | Schwartz et al. | Mar 2008 | A1 |
20080064965 | Jay et al. | Mar 2008 | A1 |
20080076972 | Dorogusker et al. | Mar 2008 | A1 |
20080090626 | Griffin et al. | Apr 2008 | A1 |
20080091089 | Guillory et al. | Apr 2008 | A1 |
20080091090 | Guillory et al. | Apr 2008 | A1 |
20080091471 | Michon et al. | Apr 2008 | A1 |
20080094228 | Welch et al. | Apr 2008 | A1 |
20080097167 | Yudkovitch et al. | Apr 2008 | A1 |
20080099366 | Niemiec et al. | May 2008 | A1 |
20080108884 | Kiani | May 2008 | A1 |
20080119412 | Tymianski et al. | May 2008 | A1 |
20080138278 | Scherz et al. | Jun 2008 | A1 |
20080169922 | Issokson | Jul 2008 | A1 |
20080171919 | Stivoric et al. | Jul 2008 | A1 |
20080188795 | Katz et al. | Aug 2008 | A1 |
20080194918 | Kulik et al. | Aug 2008 | A1 |
20080198822 | Magnusson et al. | Aug 2008 | A1 |
20080208912 | Garibaldi | Aug 2008 | A1 |
20080215627 | Higgins et al. | Sep 2008 | A1 |
20080221396 | Garces et al. | Sep 2008 | A1 |
20080221418 | Al-Ali et al. | Sep 2008 | A1 |
20080228045 | Gao et al. | Sep 2008 | A1 |
20080228077 | Wilk et al. | Sep 2008 | A1 |
20080275309 | Stivoric et al. | Nov 2008 | A1 |
20080281167 | Soderberg et al. | Nov 2008 | A1 |
20080281168 | Gibson et al. | Nov 2008 | A1 |
20080281181 | Manzione et al. | Nov 2008 | A1 |
20080287751 | Stivoric et al. | Nov 2008 | A1 |
20080292172 | Assmann et al. | Nov 2008 | A1 |
20080300020 | Nishizawa et al. | Dec 2008 | A1 |
20080319275 | Chiu et al. | Dec 2008 | A1 |
20080319354 | Bell et al. | Dec 2008 | A1 |
20090005651 | Ward et al. | Jan 2009 | A1 |
20090018808 | Bronstein et al. | Jan 2009 | A1 |
20090024008 | Brunner et al. | Jan 2009 | A1 |
20090036759 | Ault et al. | Feb 2009 | A1 |
20090043172 | Zagorchev et al. | Feb 2009 | A1 |
20090052623 | Tome et al. | Feb 2009 | A1 |
20090054735 | Higgins et al. | Feb 2009 | A1 |
20090062682 | Bland et al. | Mar 2009 | A1 |
20090069642 | Gao et al. | Mar 2009 | A1 |
20090081951 | Erdmann et al. | Mar 2009 | A1 |
20090093687 | Telfort et al. | Apr 2009 | A1 |
20090095926 | MacNeish, III | Apr 2009 | A1 |
20090099480 | Saigo et al. | Apr 2009 | A1 |
20090119330 | Sampath et al. | May 2009 | A1 |
20090119843 | Rodgers et al. | May 2009 | A1 |
20090124867 | Hirsch et al. | May 2009 | A1 |
20090131759 | Sims et al. | May 2009 | A1 |
20090143832 | Saba | Jun 2009 | A1 |
20090154432 | Hassan et al. | Jun 2009 | A1 |
20090157058 | Ferren et al. | Jun 2009 | A1 |
20090171170 | Li et al. | Jul 2009 | A1 |
20090171225 | Gadodia et al. | Jul 2009 | A1 |
20090177090 | Grunwald et al. | Jul 2009 | A1 |
20090182287 | Kassab | Jul 2009 | A1 |
20090221887 | Mannheimer et al. | Sep 2009 | A1 |
20090226372 | Ruoslahti et al. | Sep 2009 | A1 |
20090247984 | Lamego et al. | Oct 2009 | A1 |
20090264778 | Markowitz et al. | Oct 2009 | A1 |
20090275813 | Davis | Nov 2009 | A1 |
20090275844 | Al-Ali | Nov 2009 | A1 |
20090281462 | Heliot et al. | Nov 2009 | A1 |
20090299157 | Telfort et al. | Dec 2009 | A1 |
20090309755 | Williamson et al. | Dec 2009 | A1 |
20090322540 | Richardson et al. | Dec 2009 | A1 |
20090326386 | Sethi et al. | Dec 2009 | A1 |
20100004518 | Vo et al. | Jan 2010 | A1 |
20100030040 | Poeze et al. | Feb 2010 | A1 |
20100030094 | Lundback | Feb 2010 | A1 |
20100036209 | Ferren et al. | Feb 2010 | A1 |
20100060747 | Woodman | Mar 2010 | A1 |
20100069725 | Al-Ali | Mar 2010 | A1 |
20100081895 | Zand | Apr 2010 | A1 |
20100099964 | O'Reilly et al. | Apr 2010 | A1 |
20100114254 | Kornet | May 2010 | A1 |
20100125217 | Kuo et al. | May 2010 | A1 |
20100144627 | Vitek et al. | Jun 2010 | A1 |
20100145146 | Melder | Jun 2010 | A1 |
20100177100 | Carnes et al. | Jul 2010 | A1 |
20100182518 | Kirmse et al. | Jul 2010 | A1 |
20100185101 | Sakai et al. | Jul 2010 | A1 |
20100198622 | Gajic et al. | Aug 2010 | A1 |
20100210958 | Manwaring et al. | Aug 2010 | A1 |
20100234706 | Gilland | Sep 2010 | A1 |
20100234718 | Sampath et al. | Sep 2010 | A1 |
20100240945 | Bikko | Sep 2010 | A1 |
20100241115 | Benamou et al. | Sep 2010 | A1 |
20100249540 | Lisogurski | Sep 2010 | A1 |
20100270257 | Wachman et al. | Oct 2010 | A1 |
20100298651 | Moon et al. | Nov 2010 | A1 |
20100298657 | McCombie et al. | Nov 2010 | A1 |
20100298659 | McCombie et al. | Nov 2010 | A1 |
20100298661 | McCombie et al. | Nov 2010 | A1 |
20100298742 | Perlman et al. | Nov 2010 | A1 |
20100305412 | Darrah et al. | Dec 2010 | A1 |
20100312103 | Gorek et al. | Dec 2010 | A1 |
20100317936 | Al-Ali et al. | Dec 2010 | A1 |
20100317951 | Rutkowski et al. | Dec 2010 | A1 |
20110015533 | Cox et al. | Jan 2011 | A1 |
20110021930 | Mazzeo et al. | Jan 2011 | A1 |
20110023130 | Gudgel et al. | Jan 2011 | A1 |
20110028806 | Merritt et al. | Feb 2011 | A1 |
20110028809 | Goodman | Feb 2011 | A1 |
20110040197 | Welch et al. | Feb 2011 | A1 |
20110046495 | Osypka | Feb 2011 | A1 |
20110066051 | Moon et al. | Mar 2011 | A1 |
20110077473 | Lisogurski | Mar 2011 | A1 |
20110077487 | Buxton et al. | Mar 2011 | A1 |
20110078596 | Rawlins et al. | Mar 2011 | A1 |
20110080294 | Tanishima et al. | Apr 2011 | A1 |
20110082711 | Poeze et al. | Apr 2011 | A1 |
20110084850 | Jiang et al. | Apr 2011 | A1 |
20110087081 | Kiani et al. | Apr 2011 | A1 |
20110087083 | Poeze et al. | Apr 2011 | A1 |
20110087084 | Jeong et al. | Apr 2011 | A1 |
20110087117 | Tremper et al. | Apr 2011 | A1 |
20110087756 | Biondi | Apr 2011 | A1 |
20110098583 | Pandia et al. | Apr 2011 | A1 |
20110105854 | Kiani et al. | May 2011 | A1 |
20110105956 | Hirth | May 2011 | A1 |
20110118561 | Tari et al. | May 2011 | A1 |
20110118573 | Mckenna | May 2011 | A1 |
20110118616 | Vajdic et al. | May 2011 | A1 |
20110125060 | Telfort et al. | May 2011 | A1 |
20110137297 | Kiani et al. | Jun 2011 | A1 |
20110148622 | Judy et al. | Jun 2011 | A1 |
20110149871 | Liu et al. | Jun 2011 | A1 |
20110152629 | Eaton et al. | Jun 2011 | A1 |
20110172498 | Olsen et al. | Jul 2011 | A1 |
20110172967 | Al-Ali et al. | Jul 2011 | A1 |
20110184252 | Archer et al. | Jul 2011 | A1 |
20110184253 | Archer et al. | Jul 2011 | A1 |
20110193704 | Harper | Aug 2011 | A1 |
20110208015 | Welch et al. | Aug 2011 | A1 |
20110208018 | Kiani | Aug 2011 | A1 |
20110208073 | Matsukawa et al. | Aug 2011 | A1 |
20110209915 | Telfort et al. | Sep 2011 | A1 |
20110212090 | Pedersen et al. | Sep 2011 | A1 |
20110212746 | Sarkar et al. | Sep 2011 | A1 |
20110213212 | Al-Ali | Sep 2011 | A1 |
20110227739 | Gilham et al. | Sep 2011 | A1 |
20110230733 | Al-Ali | Sep 2011 | A1 |
20110237911 | Lamego et al. | Sep 2011 | A1 |
20110237969 | Eckerbom et al. | Sep 2011 | A1 |
20110257544 | Kaasinen et al. | Oct 2011 | A1 |
20110257554 | Banet et al. | Oct 2011 | A1 |
20110263950 | Larson et al. | Oct 2011 | A1 |
20110288383 | Diab | Nov 2011 | A1 |
20110295094 | Doyle et al. | Dec 2011 | A1 |
20110301444 | Al-Ali | Dec 2011 | A1 |
20110307274 | Thompson et al. | Dec 2011 | A1 |
20120004579 | Luo et al. | Jan 2012 | A1 |
20120029300 | Paquet | Feb 2012 | A1 |
20120029879 | Sing et al. | Feb 2012 | A1 |
20120041316 | Al-Ali et al. | Feb 2012 | A1 |
20120046557 | Kiani | Feb 2012 | A1 |
20120059230 | Teller et al. | Mar 2012 | A1 |
20120059267 | Lamego et al. | Mar 2012 | A1 |
20120071771 | Behar | Mar 2012 | A1 |
20120075464 | Derenne et al. | Mar 2012 | A1 |
20120088984 | Al-Ali et al. | Apr 2012 | A1 |
20120101353 | Reggiardo et al. | Apr 2012 | A1 |
20120102455 | Ambat et al. | Apr 2012 | A1 |
20120116175 | Al-Ali et al. | May 2012 | A1 |
20120123231 | O'Reilly | May 2012 | A1 |
20120123799 | Nolen et al. | May 2012 | A1 |
20120127103 | Qualey et al. | May 2012 | A1 |
20120136221 | Killen et al. | May 2012 | A1 |
20120165629 | Merritt et al. | Jun 2012 | A1 |
20120179006 | Jansen et al. | Jul 2012 | A1 |
20120184120 | Basta et al. | Jul 2012 | A1 |
20120197619 | Namer Yelin et al. | Aug 2012 | A1 |
20120198341 | Pekarske et al. | Aug 2012 | A1 |
20120203078 | Sze et al. | Aug 2012 | A1 |
20120209082 | Al-Ali | Aug 2012 | A1 |
20120209084 | Olsen et al. | Aug 2012 | A1 |
20120221634 | Treu et al. | Aug 2012 | A1 |
20120224694 | Lu et al. | Sep 2012 | A1 |
20120226117 | Lamego et al. | Sep 2012 | A1 |
20120226160 | Kudoh | Sep 2012 | A1 |
20120227739 | Kiani | Sep 2012 | A1 |
20120239434 | Breslow et al. | Sep 2012 | A1 |
20120242501 | Tran et al. | Sep 2012 | A1 |
20120265039 | Kiani | Oct 2012 | A1 |
20120275392 | Haddad | Nov 2012 | A1 |
20120282583 | Thaler et al. | Nov 2012 | A1 |
20120283524 | Kiani et al. | Nov 2012 | A1 |
20120284053 | Rosenfeld | Nov 2012 | A1 |
20120286955 | Welch et al. | Nov 2012 | A1 |
20120294801 | Scherz et al. | Nov 2012 | A1 |
20120296178 | Lamego et al. | Nov 2012 | A1 |
20120302894 | Diab et al. | Nov 2012 | A1 |
20120303476 | Krzyzanowski et al. | Nov 2012 | A1 |
20120319816 | Al-Ali | Dec 2012 | A1 |
20120330112 | Lamego et al. | Dec 2012 | A1 |
20130006131 | Narayan et al. | Jan 2013 | A1 |
20130006151 | Main et al. | Jan 2013 | A1 |
20130023775 | Lamego et al. | Jan 2013 | A1 |
20130035603 | Jarausch et al. | Feb 2013 | A1 |
20130041591 | Lamego | Feb 2013 | A1 |
20130046197 | Dlugos, Jr. et al. | Feb 2013 | A1 |
20130046204 | Lamego et al. | Feb 2013 | A1 |
20130060108 | Schurman et al. | Mar 2013 | A1 |
20130060147 | Welch et al. | Mar 2013 | A1 |
20130079610 | Al-Ali | Mar 2013 | A1 |
20130092805 | Funk et al. | Apr 2013 | A1 |
20130096405 | Garfio | Apr 2013 | A1 |
20130096936 | Sampath et al. | Apr 2013 | A1 |
20130109929 | Menzel | May 2013 | A1 |
20130109935 | Al-Ali et al. | May 2013 | A1 |
20130123616 | Merritt et al. | May 2013 | A1 |
20130162433 | Muhsin et al. | Jun 2013 | A1 |
20130178718 | Tran et al. | Jul 2013 | A1 |
20130178749 | Lamego | Jul 2013 | A1 |
20130190581 | Al-Ali et al. | Jul 2013 | A1 |
20130191513 | Kamen et al. | Jul 2013 | A1 |
20130197328 | Diab et al. | Aug 2013 | A1 |
20130197364 | Han | Aug 2013 | A1 |
20130211214 | Olsen | Aug 2013 | A1 |
20130243021 | Siskavich | Sep 2013 | A1 |
20130253334 | Al-Ali et al. | Sep 2013 | A1 |
20130261494 | Bloom et al. | Oct 2013 | A1 |
20130267793 | Meador et al. | Oct 2013 | A1 |
20130267804 | Al-Ali | Oct 2013 | A1 |
20130274571 | Diab et al. | Oct 2013 | A1 |
20130274572 | Al-Ali et al. | Oct 2013 | A1 |
20130279109 | Lindblad et al. | Oct 2013 | A1 |
20130286853 | Shi et al. | Oct 2013 | A1 |
20130296672 | O'Neil et al. | Nov 2013 | A1 |
20130296713 | Al-Ali et al. | Nov 2013 | A1 |
20130317327 | Al-Ali et al. | Nov 2013 | A1 |
20130317370 | Dalvi et al. | Nov 2013 | A1 |
20130317393 | Weiss et al. | Nov 2013 | A1 |
20130324804 | McKeown et al. | Dec 2013 | A1 |
20130324808 | Al-Ali et al. | Dec 2013 | A1 |
20130324817 | Diab | Dec 2013 | A1 |
20130331054 | Kodali | Dec 2013 | A1 |
20130331660 | Al-Ali et al. | Dec 2013 | A1 |
20130331670 | Kiani | Dec 2013 | A1 |
20130332011 | Ziarno | Dec 2013 | A1 |
20130338461 | Lamego et al. | Dec 2013 | A1 |
20130340176 | Stevens et al. | Dec 2013 | A1 |
20130344872 | Nukala et al. | Dec 2013 | A1 |
20130345921 | Al-Ali et al. | Dec 2013 | A1 |
20140012100 | Al-Ali et al. | Jan 2014 | A1 |
20140022081 | Ribble et al. | Jan 2014 | A1 |
20140025306 | Weber et al. | Jan 2014 | A1 |
20140031650 | Weber et al. | Jan 2014 | A1 |
20140034353 | Al-Ali et al. | Feb 2014 | A1 |
20140046674 | Rosenfeld | Feb 2014 | A1 |
20140051952 | Reichgott et al. | Feb 2014 | A1 |
20140051953 | Lamego et al. | Feb 2014 | A1 |
20140051954 | Al-Ali et al. | Feb 2014 | A1 |
20140058230 | Abdul-Hafiz et al. | Feb 2014 | A1 |
20140066783 | Kiani et al. | Mar 2014 | A1 |
20140073167 | Al-Ali et al. | Mar 2014 | A1 |
20140077956 | Sampath et al. | Mar 2014 | A1 |
20140081097 | Al-Ali et al. | Mar 2014 | A1 |
20140081100 | Muhsin et al. | Mar 2014 | A1 |
20140081175 | Telfort | Mar 2014 | A1 |
20140094667 | Schurman et al. | Apr 2014 | A1 |
20140100434 | Diab et al. | Apr 2014 | A1 |
20140114199 | Lamego et al. | Apr 2014 | A1 |
20140120564 | Workman et al. | May 2014 | A1 |
20140121482 | Merritt et al. | May 2014 | A1 |
20140121483 | Kiani | May 2014 | A1 |
20140127137 | Bellott et al. | May 2014 | A1 |
20140128696 | Al-Ali | May 2014 | A1 |
20140128699 | Al-Ali et al. | May 2014 | A1 |
20140129702 | Lamego et al. | May 2014 | A1 |
20140135588 | Al-Ali et al. | May 2014 | A1 |
20140142399 | Al-Ali et al. | May 2014 | A1 |
20140142401 | Al-Ali et al. | May 2014 | A1 |
20140142402 | Al-Ali et al. | May 2014 | A1 |
20140152673 | Lynn et al. | Jun 2014 | A1 |
20140155712 | Lamego et al. | Jun 2014 | A1 |
20140163344 | Al-Ali | Jun 2014 | A1 |
20140163402 | Lamego et al. | Jun 2014 | A1 |
20140166076 | Kiani et al. | Jun 2014 | A1 |
20140171763 | Diab | Jun 2014 | A1 |
20140180038 | Kiani | Jun 2014 | A1 |
20140180154 | Sierra et al. | Jun 2014 | A1 |
20140180160 | Brown et al. | Jun 2014 | A1 |
20140187973 | Brown et al. | Jul 2014 | A1 |
20140188516 | Kamen | Jul 2014 | A1 |
20140194709 | Al-Ali et al. | Jul 2014 | A1 |
20140194711 | Al-Ali | Jul 2014 | A1 |
20140194766 | Al-Ali et al. | Jul 2014 | A1 |
20140200422 | Weber et al. | Jul 2014 | A1 |
20140206963 | Al-Ali | Jul 2014 | A1 |
20140213864 | Abdul-Hafiz et al. | Jul 2014 | A1 |
20140243627 | Diab et al. | Aug 2014 | A1 |
20140257057 | Reis Cunha et al. | Sep 2014 | A1 |
20140266787 | Tran | Sep 2014 | A1 |
20140266790 | Al-Ali et al. | Sep 2014 | A1 |
20140275808 | Poeze et al. | Sep 2014 | A1 |
20140275835 | Lamego et al. | Sep 2014 | A1 |
20140275871 | Lamego et al. | Sep 2014 | A1 |
20140275872 | Merritt et al. | Sep 2014 | A1 |
20140275881 | Lamego et al. | Sep 2014 | A1 |
20140276115 | Dalvi et al. | Sep 2014 | A1 |
20140288400 | Diab et al. | Sep 2014 | A1 |
20140296664 | Bruinsma et al. | Oct 2014 | A1 |
20140303520 | Telfort et al. | Oct 2014 | A1 |
20140309506 | Lamego et al. | Oct 2014 | A1 |
20140309559 | Telfort et al. | Oct 2014 | A1 |
20140316217 | Purdon et al. | Oct 2014 | A1 |
20140316218 | Purdon et al. | Oct 2014 | A1 |
20140316228 | Blank et al. | Oct 2014 | A1 |
20140323825 | Al-Ali et al. | Oct 2014 | A1 |
20140323897 | Brown et al. | Oct 2014 | A1 |
20140323898 | Purdon et al. | Oct 2014 | A1 |
20140330092 | Al-Ali et al. | Nov 2014 | A1 |
20140330098 | Merritt et al. | Nov 2014 | A1 |
20140330099 | Al-Ali et al. | Nov 2014 | A1 |
20140333440 | Kiani | Nov 2014 | A1 |
20140336481 | Shakespeare et al. | Nov 2014 | A1 |
20140343436 | Kiani | Nov 2014 | A1 |
20140343889 | Ben Shalom et al. | Nov 2014 | A1 |
20140357966 | Al-Ali et al. | Dec 2014 | A1 |
20140371548 | Al-Ali et al. | Dec 2014 | A1 |
20140371632 | Al-Ali et al. | Dec 2014 | A1 |
20140378784 | Kiani et al. | Dec 2014 | A1 |
20150001302 | Gelay et al. | Jan 2015 | A1 |
20150005600 | Blank et al. | Jan 2015 | A1 |
20150006089 | Pagels | Jan 2015 | A1 |
20150007075 | Choi et al. | Jan 2015 | A1 |
20150011907 | Purdon et al. | Jan 2015 | A1 |
20150012231 | Poeze et al. | Jan 2015 | A1 |
20150018650 | Al-Ali et al. | Jan 2015 | A1 |
20150025406 | Al-Ali | Jan 2015 | A1 |
20150032029 | Al-Ali et al. | Jan 2015 | A1 |
20150038859 | Dalvi et al. | Feb 2015 | A1 |
20150045637 | Dalvi | Feb 2015 | A1 |
20150051462 | Olsen | Feb 2015 | A1 |
20150073241 | Lamego | Mar 2015 | A1 |
20150080754 | Purdon et al. | Mar 2015 | A1 |
20150087936 | Al-Ali et al. | Mar 2015 | A1 |
20150094546 | Al-Ali | Apr 2015 | A1 |
20150094618 | Russell et al. | Apr 2015 | A1 |
20150097701 | Al-Ali et al. | Apr 2015 | A1 |
20150099950 | Al-Ali et al. | Apr 2015 | A1 |
20150099951 | Al-Ali et al. | Apr 2015 | A1 |
20150099955 | Al-Ali et al. | Apr 2015 | A1 |
20150101844 | Al-Ali et al. | Apr 2015 | A1 |
20150106121 | Muhsin et al. | Apr 2015 | A1 |
20150112151 | Muhsin et al. | Apr 2015 | A1 |
20150116076 | Al-Ali et al. | Apr 2015 | A1 |
20150126830 | Schurman et al. | May 2015 | A1 |
20150133755 | Smith et al. | May 2015 | A1 |
20150140863 | Al-Ali et al. | May 2015 | A1 |
20150141781 | Weber et al. | May 2015 | A1 |
20150165312 | Kiani | Jun 2015 | A1 |
20150196237 | Lamego | Jul 2015 | A1 |
20150196249 | Brown et al. | Jul 2015 | A1 |
20150201874 | Diab | Jul 2015 | A1 |
20150208966 | Al-Ali | Jul 2015 | A1 |
20150216459 | Al-Ali et al. | Aug 2015 | A1 |
20150230755 | Al-Ali et al. | Aug 2015 | A1 |
20150238722 | Al-Ali | Aug 2015 | A1 |
20150245773 | Lamego et al. | Sep 2015 | A1 |
20150245794 | Al-Ali | Sep 2015 | A1 |
20150257689 | Al-Ali et al. | Sep 2015 | A1 |
20150264506 | Balabanis et al. | Sep 2015 | A1 |
20150272514 | Kiani et al. | Oct 2015 | A1 |
20150351697 | Weber et al. | Dec 2015 | A1 |
20150358314 | Glik et al. | Dec 2015 | A1 |
20150359429 | Al-Ali et al. | Dec 2015 | A1 |
20150366472 | Kiani | Dec 2015 | A1 |
20150366507 | Blank et al. | Dec 2015 | A1 |
20150374298 | Al-Ali et al. | Dec 2015 | A1 |
20150380875 | Coverston et al. | Dec 2015 | A1 |
20160000362 | Diab et al. | Jan 2016 | A1 |
20160007930 | Weber et al. | Jan 2016 | A1 |
20160029932 | Al-Ali | Feb 2016 | A1 |
20160029933 | Al-Ali et al. | Feb 2016 | A1 |
20160045118 | Kiani | Feb 2016 | A1 |
20160051205 | Al-Ali et al. | Feb 2016 | A1 |
20160058338 | Schurman et al. | Mar 2016 | A1 |
20160058347 | Reichgott et al. | Mar 2016 | A1 |
20160066823 | Al-Ali et al. | Mar 2016 | A1 |
20160066824 | Al-Ali et al. | Mar 2016 | A1 |
20160066879 | Telfort et al. | Mar 2016 | A1 |
20160072429 | Kiani et al. | Mar 2016 | A1 |
20160073967 | Lamego et al. | Mar 2016 | A1 |
20160081552 | Wojtczuk et al. | Mar 2016 | A1 |
20160095543 | Telfort et al. | Apr 2016 | A1 |
20160095548 | Al-Ali et al. | Apr 2016 | A1 |
20160103598 | Al-Ali et al. | Apr 2016 | A1 |
20160113527 | Al-Ali | Apr 2016 | A1 |
20160143548 | Al-Ali | May 2016 | A1 |
20160166182 | Al-Ali et al. | Jun 2016 | A1 |
20160166183 | Poeze et al. | Jun 2016 | A1 |
20160166188 | Bruinsma et al. | Jun 2016 | A1 |
20160166210 | Al-Ali | Jun 2016 | A1 |
20160192869 | Kiani et al. | Jul 2016 | A1 |
20160196388 | Lamego | Jul 2016 | A1 |
20160197436 | Barker et al. | Jul 2016 | A1 |
20160213281 | Eckerbom et al. | Jul 2016 | A1 |
20160216117 | Bandyopadhyay et al. | Jul 2016 | A9 |
20160228043 | O'Neil et al. | Aug 2016 | A1 |
20160233632 | Scruggs et al. | Aug 2016 | A1 |
20160234944 | Triman et al. | Aug 2016 | A1 |
20160246781 | Cabot | Aug 2016 | A1 |
20160270717 | Luna et al. | Sep 2016 | A1 |
20160270735 | Diab et al. | Sep 2016 | A1 |
20160271445 | Kolloff | Sep 2016 | A1 |
20160283665 | Sampath et al. | Sep 2016 | A1 |
20160287786 | Kiani | Oct 2016 | A1 |
20160296169 | McHale et al. | Oct 2016 | A1 |
20160310052 | Al-Ali et al. | Oct 2016 | A1 |
20160314260 | Kiani | Oct 2016 | A1 |
20160324486 | Al-Ali et al. | Nov 2016 | A1 |
20160324488 | Olsen | Nov 2016 | A1 |
20160327984 | Al-Ali et al. | Nov 2016 | A1 |
20160331332 | Al-Ali | Nov 2016 | A1 |
20160367173 | Dalvi et al. | Dec 2016 | A1 |
20170000394 | Al-Ali et al. | Jan 2017 | A1 |
20170007134 | Al-Ali et al. | Jan 2017 | A1 |
20170014083 | Diab et al. | Jan 2017 | A1 |
20170014084 | Al-Ali et al. | Jan 2017 | A1 |
20170024748 | Haider | Jan 2017 | A1 |
20170042488 | Muhsin | Feb 2017 | A1 |
20170055851 | Al-Ali et al. | Mar 2017 | A1 |
20170055882 | Al-Ali et al. | Mar 2017 | A1 |
20170055887 | Al-Ali | Mar 2017 | A1 |
20170055896 | Al-Ali et al. | Mar 2017 | A1 |
20170079594 | Telfort et al. | Mar 2017 | A1 |
20170086723 | Al-Ali et al. | Mar 2017 | A1 |
20170143281 | Olsen | May 2017 | A1 |
20170147774 | Kiani | May 2017 | A1 |
20170156620 | Al-Ali et al. | Jun 2017 | A1 |
20170173632 | Al-Ali | Jun 2017 | A1 |
20170187146 | Kiani et al. | Jun 2017 | A1 |
20170188919 | Al-Ali et al. | Jul 2017 | A1 |
20170196464 | Jansen et al. | Jul 2017 | A1 |
20170196470 | Lamego et al. | Jul 2017 | A1 |
20170224262 | Al-Ali | Aug 2017 | A1 |
20170228516 | Sampath et al. | Aug 2017 | A1 |
20170245790 | Al-Ali et al. | Aug 2017 | A1 |
20170251974 | Shreim et al. | Sep 2017 | A1 |
20170251975 | Shreim et al. | Sep 2017 | A1 |
20170258403 | Abdul-Hafiz et al. | Sep 2017 | A1 |
20170311851 | Schurman et al. | Nov 2017 | A1 |
20170311891 | Kiani et al. | Nov 2017 | A1 |
20170325728 | Al-Ali et al. | Nov 2017 | A1 |
20170332976 | Al-Ali et al. | Nov 2017 | A1 |
20170340293 | Al-Ali et al. | Nov 2017 | A1 |
20170360310 | Kiani et al. | Dec 2017 | A1 |
20170367632 | Al-Ali et al. | Dec 2017 | A1 |
20180008146 | Al-Ali et al. | Jan 2018 | A1 |
20180013562 | Haider et al. | Jan 2018 | A1 |
20180014752 | Al-Ali et al. | Jan 2018 | A1 |
20180028124 | Al-Ali et al. | Feb 2018 | A1 |
20180055385 | Al-Ali | Mar 2018 | A1 |
20180055390 | Kiani et al. | Mar 2018 | A1 |
20180055430 | Diab et al. | Mar 2018 | A1 |
20180064381 | Shakespeare et al. | Mar 2018 | A1 |
20180069776 | Lamego et al. | Mar 2018 | A1 |
20180070867 | Smith et al. | Mar 2018 | A1 |
20180082767 | Al-Ali et al. | Mar 2018 | A1 |
20180085068 | Telfort | Mar 2018 | A1 |
20180087937 | Al-Ali et al. | Mar 2018 | A1 |
20180103874 | Lee et al. | Apr 2018 | A1 |
20180103905 | Kiani | Apr 2018 | A1 |
20180110478 | Al-Ali | Apr 2018 | A1 |
20180116575 | Perea et al. | May 2018 | A1 |
20180125368 | Lamego et al. | May 2018 | A1 |
20180125430 | Al-Ali et al. | May 2018 | A1 |
20180125445 | Telfort et al. | May 2018 | A1 |
20180130325 | Kiani et al. | May 2018 | A1 |
20180132769 | Weber et al. | May 2018 | A1 |
20180132770 | Lamego | May 2018 | A1 |
20180146901 | Al-Ali et al. | May 2018 | A1 |
20180146902 | Kiani et al. | May 2018 | A1 |
20180153442 | Eckerbom et al. | Jun 2018 | A1 |
20180153446 | Kiani | Jun 2018 | A1 |
20180153447 | Al-Ali et al. | Jun 2018 | A1 |
20180153448 | Weber et al. | Jun 2018 | A1 |
20180161499 | Al-Ali et al. | Jun 2018 | A1 |
20180168491 | Al-Ali et al. | Jun 2018 | A1 |
20180174679 | Sampath et al. | Jun 2018 | A1 |
20180174680 | Sampath et al. | Jun 2018 | A1 |
20180182484 | Sampath et al. | Jun 2018 | A1 |
20180184917 | Kiani | Jul 2018 | A1 |
20180192924 | Al-Ali | Jul 2018 | A1 |
20180192953 | Shreim et al. | Jul 2018 | A1 |
20180192955 | Al-Ali et al. | Jul 2018 | A1 |
20180199871 | Pauley et al. | Jul 2018 | A1 |
20180206795 | Al-Ali | Jul 2018 | A1 |
20180206815 | Telfort | Jul 2018 | A1 |
20180213583 | Al-Ali | Jul 2018 | A1 |
20180214031 | Kiani et al. | Aug 2018 | A1 |
20180214090 | Al-Ali et al. | Aug 2018 | A1 |
20180216370 | Ishiguro et al. | Aug 2018 | A1 |
20180218792 | Muhsin et al. | Aug 2018 | A1 |
20180225960 | Al-Ali et al. | Aug 2018 | A1 |
20180238718 | Dalvi | Aug 2018 | A1 |
20180242853 | Al-Ali | Aug 2018 | A1 |
20180242921 | Muhsin et al. | Aug 2018 | A1 |
20180242923 | Al-Ali et al. | Aug 2018 | A1 |
20180242924 | Barker et al. | Aug 2018 | A1 |
20180242926 | Muhsin et al. | Aug 2018 | A1 |
20180247353 | Al-Ali et al. | Aug 2018 | A1 |
20180247712 | Muhsin et al. | Aug 2018 | A1 |
20180249933 | Schurman et al. | Sep 2018 | A1 |
20180253947 | Muhsin et al. | Sep 2018 | A1 |
20180256087 | Al-Ali et al. | Sep 2018 | A1 |
20180256113 | Weber et al. | Sep 2018 | A1 |
20180285094 | Housel et al. | Oct 2018 | A1 |
20180289325 | Poeze et al. | Oct 2018 | A1 |
20180289337 | Al-Ali et al. | Oct 2018 | A1 |
20180296161 | Shreim et al. | Oct 2018 | A1 |
20180300919 | Muhsin et al. | Oct 2018 | A1 |
20180310822 | Indorf et al. | Nov 2018 | A1 |
20180310823 | Al-Ali et al. | Nov 2018 | A1 |
20180317826 | Muhsin | Nov 2018 | A1 |
20180317841 | Novak, Jr. | Nov 2018 | A1 |
20180333055 | Lamego et al. | Nov 2018 | A1 |
20180333087 | Al-Ali | Nov 2018 | A1 |
20190000317 | Muhsin et al. | Jan 2019 | A1 |
20190000362 | Kiani et al. | Jan 2019 | A1 |
20190015023 | Monfre | Jan 2019 | A1 |
20190021638 | Al-Ali et al. | Jan 2019 | A1 |
20190029574 | Schurman et al. | Jan 2019 | A1 |
20190029578 | Al-Ali et al. | Jan 2019 | A1 |
20190038143 | Al-Ali | Feb 2019 | A1 |
20190053286 | Cho et al. | Feb 2019 | A1 |
20190058280 | Al-Ali et al. | Feb 2019 | A1 |
20190058281 | Al-Ali et al. | Feb 2019 | A1 |
20190069813 | Al-Ali | Mar 2019 | A1 |
20190069814 | Al-Ali | Mar 2019 | A1 |
20190076028 | Al-Ali et al. | Mar 2019 | A1 |
20190082979 | Al-Ali et al. | Mar 2019 | A1 |
20190090748 | Al-Ali | Mar 2019 | A1 |
20190090760 | Kinast et al. | Mar 2019 | A1 |
20190090764 | Al-Ali | Mar 2019 | A1 |
20190104973 | Poeze et al. | Apr 2019 | A1 |
20190110719 | Poeze et al. | Apr 2019 | A1 |
20190117070 | Muhsin et al. | Apr 2019 | A1 |
20190117139 | Al-Ali et al. | Apr 2019 | A1 |
20190117140 | Al-Ali et al. | Apr 2019 | A1 |
20190117141 | Al-Ali | Apr 2019 | A1 |
20190117930 | Al-Ali | Apr 2019 | A1 |
20190122763 | Sampath et al. | Apr 2019 | A1 |
20190133525 | Al-Ali et al. | May 2019 | A1 |
20190142283 | Lamego et al. | May 2019 | A1 |
20190142344 | Telfort et al. | May 2019 | A1 |
20190150856 | Kiani et al. | May 2019 | A1 |
20190167161 | Al-Ali et al. | Jun 2019 | A1 |
20190175019 | Al-Ali et al. | Jun 2019 | A1 |
20190192076 | McHale et al. | Jun 2019 | A1 |
20190200941 | Chandran et al. | Jul 2019 | A1 |
20190201623 | Kiani | Jul 2019 | A1 |
20190209025 | Al-Ali | Jul 2019 | A1 |
20190214778 | Scruggs et al. | Jul 2019 | A1 |
20190216319 | Poeze et al. | Jul 2019 | A1 |
20190216379 | Al-Ali et al. | Jul 2019 | A1 |
20190221966 | Kiani et al. | Jul 2019 | A1 |
20190223804 | Blank et al. | Jul 2019 | A1 |
20190231199 | Al-Ali et al. | Aug 2019 | A1 |
20190231241 | Al-Ali et al. | Aug 2019 | A1 |
20190231270 | Abdul-Hafiz et al. | Aug 2019 | A1 |
20190239787 | Pauley et al. | Aug 2019 | A1 |
20190239824 | Muhsin et al. | Aug 2019 | A1 |
20190254578 | Lamego | Aug 2019 | A1 |
20190261857 | Al-Ali | Aug 2019 | A1 |
20190269370 | Al-Ali et al. | Sep 2019 | A1 |
20190274606 | Kiani et al. | Sep 2019 | A1 |
20190274627 | Al-Ali et al. | Sep 2019 | A1 |
20190274635 | Al-Ali et al. | Sep 2019 | A1 |
20190290136 | Dalvi et al. | Sep 2019 | A1 |
20190298270 | Al-Ali et al. | Oct 2019 | A1 |
20190304601 | Sampath et al. | Oct 2019 | A1 |
20190304605 | Al-Ali | Oct 2019 | A1 |
20190307377 | Perea et al. | Oct 2019 | A1 |
20190320906 | Olsen | Oct 2019 | A1 |
20190320959 | Al-Ali | Oct 2019 | A1 |
20190320988 | Ahmed et al. | Oct 2019 | A1 |
20190325722 | Kiani | Oct 2019 | A1 |
20190374139 | Kiani et al. | Dec 2019 | A1 |
20190374173 | Kiani et al. | Dec 2019 | A1 |
20190374713 | Kiani et al. | Dec 2019 | A1 |
20200060869 | Telfort et al. | Feb 2020 | A1 |
20200111552 | Ahmed | Apr 2020 | A1 |
20200113435 | Muhsin | Apr 2020 | A1 |
20200113488 | Al-Ali et al. | Apr 2020 | A1 |
20200113496 | Scruggs et al. | Apr 2020 | A1 |
20200113497 | Triman et al. | Apr 2020 | A1 |
20200113520 | Abdul-Hafiz et al. | Apr 2020 | A1 |
20200138288 | Al-Ali et al. | May 2020 | A1 |
20200138368 | Kiani et al. | May 2020 | A1 |
20200163597 | Dalvi et al. | May 2020 | A1 |
20200196877 | Vo et al. | Jun 2020 | A1 |
20200253474 | Muhsin et al. | Aug 2020 | A1 |
20200253544 | Nagaraj et al. | Aug 2020 | A1 |
20200275841 | Telfort et al. | Sep 2020 | A1 |
20200288983 | Telfort et al. | Sep 2020 | A1 |
20200321793 | Al-Ali et al. | Oct 2020 | A1 |
20200329983 | Al-Ali et al. | Oct 2020 | A1 |
20200329984 | Al-Ali et al. | Oct 2020 | A1 |
20200329993 | Al-Ali et al. | Oct 2020 | A1 |
20200330037 | Al-Ali et al. | Oct 2020 | A1 |
20210022628 | Telfort et al. | Jan 2021 | A1 |
20210104173 | Pauley et al. | Apr 2021 | A1 |
20210113121 | Diab et al. | Apr 2021 | A1 |
20210117525 | Kiani et al. | Apr 2021 | A1 |
20210118581 | Kiani et al. | Apr 2021 | A1 |
20210121582 | Krishnamani et al. | Apr 2021 | A1 |
20210161465 | Barker et al. | Jun 2021 | A1 |
20210236729 | Kiani et al. | Aug 2021 | A1 |
20210256267 | Ranasinghe et al. | Aug 2021 | A1 |
20210256835 | Ranasinghe et al. | Aug 2021 | A1 |
Number | Date | Country |
---|---|---|
0 735 499 | Oct 1996 | EP |
1 110 503 | Jun 2001 | EP |
2 144 181 | Jan 2010 | EP |
2 335 569 | Jun 2011 | EP |
02-050694 | Feb 1990 | JP |
09-187428 | Jul 1997 | JP |
10-336064 | Dec 1998 | JP |
2000-312668 | Nov 2000 | JP |
2002-513602 | May 2002 | JP |
2002-165764 | Jun 2002 | JP |
2002-172096 | Jun 2002 | JP |
2002-233512 | Aug 2002 | JP |
2002-535026 | Oct 2002 | JP |
2002-542493 | Dec 2002 | JP |
2004-513732 | May 2004 | JP |
2004-321603 | Nov 2004 | JP |
2005-038417 | Feb 2005 | JP |
2005-065721 | Mar 2005 | JP |
2008-067931 | Mar 2005 | JP |
2005-218036 | Aug 2005 | JP |
2005-295375 | Oct 2005 | JP |
2005-532849 | Nov 2005 | JP |
2007-021213 | Feb 2007 | JP |
2007-095365 | Apr 2007 | JP |
2007-174051 | Jul 2007 | JP |
2008-080136 | Apr 2008 | JP |
2008-519635 | Jun 2008 | JP |
2008-541045 | Nov 2008 | JP |
2009-017959 | Jan 2009 | JP |
2009-207836 | Sep 2009 | JP |
2010-500051 | Jan 2010 | JP |
2010-503134 | Jan 2010 | JP |
2010-093543 | Apr 2010 | JP |
2010-524510 | Jul 2010 | JP |
2011-519607 | Jul 2011 | JP |
2011-519684 | Jul 2011 | JP |
2011-152261 | Aug 2011 | JP |
2012-519547 | Aug 2012 | JP |
2008-0091089 | Oct 2008 | KR |
WO 98029790 | Jul 1998 | WO |
WO 99013766 | Mar 1999 | WO |
WO 99056613 | Nov 1999 | WO |
WO 00063713 | Oct 2000 | WO |
WO 2004056266 | Jul 2004 | WO |
WO 2004059551 | Jul 2004 | WO |
WO 2006051461 | May 2006 | WO |
WO 2007143626 | Dec 2007 | WO |
WO 2009134724 | Nov 2009 | WO |
WO 2010054409 | May 2010 | WO |
WO 2011001302 | Jan 2011 | WO |
WO 2011002904 | Jan 2011 | WO |
WO 2011021948 | Feb 2011 | WO |
WO 2011025549 | Mar 2011 | WO |
WO 2011041017 | Apr 2011 | WO |
WO 2013056160 | Apr 2013 | WO |
WO 2013119982 | Aug 2013 | WO |
WO 2015054665 | Apr 2015 | WO |
Entry |
---|
US 8,845,543 B2, 09/2014, Diab et al. (withdrawn) |
U.S. Appl. No. 14/815,232, Physiological Measurement Communications Adapter, filed Jul. 31, 2015. |
U.S. Appl. No. 15/878,172, Arm Mountable Portable Patient Monitor, filed Jan. 23, 2018. |
U.S. Appl. No. 16/411,689, Physiological Measurement Device, filed May 14, 2019. |
U.S. Appl. No. 14/464,560, Modular Patient Monitor, filed Aug. 20, 2014. |
U.S. Appl. No. 12/973,392, Modular Patient Monitor, filed Dec. 20, 2010. |
U.S. Appl. No. 16/432,240, Modular Patient Monitor, filed Jun. 5, 2019. |
U.S. Appl. No. 16/182,427, Wireless Patient Monitoring Device, filed Nov. 6, 2018. |
U.S. Appl. No. 16/182,457, Wireless Patient Monitoring Device, filed Nov. 6, 2018. |
U.S. Appl. No. 15/968,392, Medical Monitoring Hub, filed May 1, 2018. |
U.S. Appl. No. 15/214,276, Medical Monitoring Hub, filed Jul. 19, 2016. |
U.S. Appl. No. 15/919,792, System for Displaying Medical Monitoring Data, filed Mar. 3, 2018. |
Capuano et al., “Remote Telemetry—New Twists for Old Technology”, Nursing Management, Jul. 1995, vol. 26, No. 7, pp. 26-32. |
Elmer-Dewitt, Philip, “Apple's iWatch: The killer apps may be in hospitals, not health clubs”, Fortune.com, Feb. 3, 2014, http://fortune.com/2014/02/03/apples-iwatch-the-killer-apps-may-be-in-hospitals-not-health-clubs/, 4 pages. |
Grundy et al., “Telemedicine in Critical Care: An Experiment in Health Care Delivery”, JACEP, Oct. 1977, vol. 6, No. 10, pp. 439-444. |
Grundy et al., “Telemedicine in Critical Care: Problems in Design, Implementation and Assessment”, Jul. 1982, vol. 10, No. 7, pp. 471-475. |
International Preliminary Report on Patentability & Written Opinion in PCT Application No. PCT/US2013/025384, dated Aug. 21, 2014. |
International Preliminary Report on Patentability & Written Opinion in PCT Application No. PCT/US2014/060177, dated Apr. 21, 2016. |
International Preliminary Reporton Patentability in PCT Application No. PCT/US2012/060109, dated Apr. 24, 2014. |
International Search Report & Written Opinion in PCT Application No. PCT/US2012/060109, dated Jun. 5, 2013. |
International Search Report & Written Opinion in PCT Application No. PCT/US2013/025384, dated Aug. 6, 2013. |
International Search Report & Written Opinion in PCT Application No. PCT/US2014/060177, dated Dec. 19, 2014. |
Rysavy, Peter, “Making the Call with Two-Way Paging”, Network Computing, Published Jan. 15, 1997, www.rysavy.com/Articles/twoway.htm, pp. 5. |
Wachter et al., “The Employment of an Iterative Design Process to Develop a Pulmonary Graphical Display”, Journal of the American Medical Informatics Association, vol. 10, No. 4, Jul./Aug. 2003, pp. 363-372. |
U.S. Appl. No. 12/840,209, Wireless Patient Monitoring System, filed Jul. 20, 2010. |
U.S. Appl. No. 13/010,653, Wireless Patient Monitoring System, filed Jan. 20, 2011. |
U.S. Appl. No. 17/141,732, Modular Patient Monitor, filed Jan. 5, 2021. |
U.S. Appl. No. 17/138,595, Wireless Patient Monitoring System, filed Dec. 30, 2020. |
U.S. Appl. No. 17/126,567, Modular Patient Monitor, filed Dec. 18, 2020. |
Liu, Chun-Hung, “A Source Coding and Modulation Method for Power Saving and Interference Reduction in DS-CDMA Sensor Network Systems”, Proceedings of the American Control Conference Anchorage, AK May 8-10, 2002, pp. 3003-3008. |
U.S. Appl. No. 17/305,155, Wireless Device Patient Monitoring, filed Jun. 30, 2021. |
Hudson, T.L., “Maximizing a Transport Platform Through Computer Technology”, Computers, Informatics, Nursing: Mar.-Apr. 2003, vol. 21, No. 2, pp. 72-79. |
Number | Date | Country | |
---|---|---|---|
20200060629 A1 | Feb 2020 | US |
Number | Date | Country | |
---|---|---|---|
61889972 | Oct 2013 | US | |
61703773 | Sep 2012 | US | |
61597120 | Feb 2012 | US | |
61547577 | Oct 2011 | US | |
61547017 | Oct 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15919792 | Mar 2018 | US |
Child | 16670051 | US | |
Parent | 14512237 | Oct 2014 | US |
Child | 15919792 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13651167 | Oct 2012 | US |
Child | 14512237 | US |